BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology. 2004;126:693-702. [PMID: 14988823 DOI: 10.1053/j.gastro.2003.11.055] [Cited by in Crossref: 915] [Cited by in F6Publishing: 823] [Article Influence: 53.8] [Reference Citation Analysis]
Number Citing Articles
1 Morellini N, Finch PM, Goebel A, Drummond PD. Dermal nerve fibre and mast cell density, and proximity of mast cells to nerve fibres in the skin of patients with complex regional pain syndrome. Pain 2018;159:2021-9. [PMID: 29905655 DOI: 10.1097/j.pain.0000000000001304] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
2 Ohlsson B, Veress B, Lindgren S, Sundkvist G. Enteric ganglioneuritis and abnormal interstitial cells of Cajal: Features of inflammatory bowel disease. Inflammatory Bowel Diseases 2007;13:721-6. [DOI: 10.1002/ibd.20095] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
3 Anand P, Singh B, Jaggi AS, Singh N. Mast cells: an expanding pathophysiological role from allergy to other disorders. Naunyn Schmiedebergs Arch Pharmacol 2012;385:657-70. [PMID: 22562473 DOI: 10.1007/s00210-012-0757-8] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
4 Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1305-1318. [PMID: 27144620 DOI: 10.1053/j.gastro.2016.02.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 87] [Article Influence: 26.8] [Reference Citation Analysis]
5 Scarpato E, Auricchio R, Penagini F, Campanozzi A, Zuccotti GV, Troncone R. Efficacy of the gluten free diet in the management of functional gastrointestinal disorders: a systematic review on behalf of the Italian Society of Paediatrics. Ital J Pediatr 2019;45:9. [PMID: 30635010 DOI: 10.1186/s13052-019-0606-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Tort S, Balboa A, Marzo M, Carrillo R, Mínguez M, Valdepérez J, Alonso-Coello P, Mascort JJ, Ferrándiz J, Bonfill X, Piqué JM, Mearin F; Centro Cochrame Iberoamericano., Asociación Española de Gastroentología., Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC). [Clinical practice guideline for irritable bowel syndrome]. Gastroenterol Hepatol 2006;29:467-521. [PMID: 17020681 DOI: 10.1157/13092567] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
7 Friesen CA, Lin Z, Singh M, Singh V, Schurman JV, Burchell N, Cocjin JT, McCallum RW. Antral inflammatory cells, gastric emptying, and electrogastrography in pediatric functional dyspepsia. Dig Dis Sci. 2008;53:2634-2640. [PMID: 18320315 DOI: 10.1007/s10620-008-0207-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
8 Bengmark S. Bioecologic control of the gastrointestinal tract: the role of flora and supplemented probiotics and synbiotics. Gastroenterol Clin North Am 2005;34:413-36, viii. [PMID: 16084305 DOI: 10.1016/j.gtc.2005.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
9 Cottrell GS, Amadesi S, Pikios S, Camerer E, Willardsen JA, Murphy BR, Caughey GH, Wolters PJ, Coughlin SR, Peterson A. Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis. Gastroenterology. 2007;132:2422-2437. [PMID: 17570216 DOI: 10.1053/j.gastro.2007.03.101] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
10 Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM. Mucosal cytokine imbalance in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1467-1476. [PMID: 18752146 DOI: 10.1080/00365520802276127] [Cited by in Crossref: 103] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
11 Iizasa H, Ishihara S, Richardo T, Kanehiro Y, Yoshiyama H. Dysbiotic infection in the stomach. World J Gastroenterol 2015;21:11450-7. [PMID: 26523109 DOI: 10.3748/wjg.v21.i40.11450] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
12 Halliez MC, Buret AG. Extra-intestinal and long term consequences of Giardia duodenalis infections. World J Gastroenterol 2013;19:8974-85. [PMID: 24379622 DOI: 10.3748/wjg.v19.i47.8974] [Cited by in CrossRef: 195] [Cited by in F6Publishing: 156] [Article Influence: 27.9] [Reference Citation Analysis]
13 Heuston S, Hyland NP. Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders? Br J Pharmacol. 2012;167:732-740. [PMID: 22646261 DOI: 10.1111/j.1476-5381.2012.02055.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
14 Brizuela M, Castro J, Harrington AM, Brierley SM. Pruritogenic mechanisms and gut sensation: putting the "irritant" into irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2021;320:G1131-41. [PMID: 33949199 DOI: 10.1152/ajpgi.00331.2020] [Reference Citation Analysis]
15 So SY, Savidge TC. Sex-Bias in Irritable Bowel Syndrome: Linking Steroids to the Gut-Brain Axis. Front Endocrinol (Lausanne) 2021;12:684096. [PMID: 34093447 DOI: 10.3389/fendo.2021.684096] [Reference Citation Analysis]
16 Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631-659. [PMID: 22782113 DOI: 10.1007/s00018-012-1070-x] [Cited by in Crossref: 569] [Cited by in F6Publishing: 509] [Article Influence: 63.2] [Reference Citation Analysis]
17 Rondeau LE, De Palma G, Caminero A. The food, the bug, and the ugly: A recipe for food-induced gut pain. Allergy 2021. [PMID: 34293818 DOI: 10.1111/all.15018] [Reference Citation Analysis]
18 Lazaridis N, Germanidis G. Current insights into the innate immune system dysfunction in irritable bowel syndrome. Ann Gastroenterol 2018;31:171-87. [PMID: 29507464 DOI: 10.20524/aog.2018.0229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
19 Bradesi S, Tillisch K, Mayer E. Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs 2006;11:293-313. [PMID: 16634703 DOI: 10.1517/14728214.11.2.293] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
20 Bafutto M, Almeida JR, Leite NV, Costa MB, Oliveira EC, Resende-Filho J. Treatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii. Arq Gastroenterol. 2013;50:304-309. [PMID: 24474234 DOI: 10.1590/s0004-28032013000400012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
21 Forshammar J, Isaksson S, Strid H, Stotzer PO, Sjövall H, Simrén M, Ohman L. A pilot study of colonic B cell pattern in irritable bowel syndrome. Scand J Gastroenterol. 2008;43:1461-1466. [PMID: 18663666 DOI: 10.1080/00365520802272126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
22 Sadeghi M, Erickson A, Castro J, Deiteren A, Harrington AM, Grundy L, Adams DJ, Brierley SM. Contribution of membrane receptor signalling to chronic visceral pain. The International Journal of Biochemistry & Cell Biology 2018;98:10-23. [DOI: 10.1016/j.biocel.2018.02.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
23 Crouzet L, Gaultier E, Del’Homme C, Cartier C, Delmas E, Dapoigny M, Fioramonti J, Bernalier-Donadille A. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil. 2013;25:e272-e282. [PMID: 23433203 DOI: 10.1111/nmo.12103] [Cited by in Crossref: 158] [Cited by in F6Publishing: 134] [Article Influence: 19.8] [Reference Citation Analysis]
24 Park SH, Eber MR, Widner DB, Shiozawa Y. Role of the Bone Microenvironment in the Development of Painful Complications of Skeletal Metastases. Cancers (Basel) 2018;10:E141. [PMID: 29747461 DOI: 10.3390/cancers10050141] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
25 Qi Q, Chen F, Zhang W, Wang P, Li Y, Zuo X. Colonic N-methyl-d-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2017;32:828-836. [PMID: 27575648 DOI: 10.1111/jgh.13588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
26 Rogers NJ, Mousa SA. The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndrome. J Altern Complement Med. 2012;18:112-119. [PMID: 22339099 DOI: 10.1089/acm.2011.0015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
27 Huh JR, Veiga-fernandes H. Neuroimmune circuits in inter-organ communication. Nat Rev Immunol 2020;20:217-28. [DOI: 10.1038/s41577-019-0247-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
28 Wackers G, Putzeys T, Peeters M, Van de Cauter L, Cornelis P, Wübbenhorst M, Tack J, Troost F, Verhaert N, Doll T, Wagner P. Towards a catheter-based impedimetric sensor for the assessment of intestinal histamine levels in IBS patients. Biosens Bioelectron 2020;158:112152. [PMID: 32275205 DOI: 10.1016/j.bios.2020.112152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
29 Mckay DM. Not all parasites are protective. Parasite Immunol 2015;37:324-32. [DOI: 10.1111/pim.12160] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
30 Pearson JS, Niven RM, Meng J, Atarodi S, Whorwell PJ. Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review. Therap Adv Gastroenterol. 2015;8:270-277. [PMID: 26327917 DOI: 10.1177/1756283x15588875] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
31 El-badry A, Sedrak H, Rashed L. Faecal calprotectin in differentiating between functional and organic bowel diseases. Arab Journal of Gastroenterology 2010;11:70-3. [DOI: 10.1016/j.ajg.2010.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
32 Nybacka S, Öhman L, Störsrud S, Mybeck M, Böhn L, Wilpart K, Winkvist A, Bengtsson U, Törnblom H, Simrén M. Neither self-reported atopy nor IgE-mediated allergy are linked to gastrointestinal symptoms in patients with irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13379. [PMID: 29856100 DOI: 10.1111/nmo.13379] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
33 Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol 2007;13:1313-32. [PMID: 17457962 DOI: 10.3748/wjg.v13.i9.1313] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
34 Leccioli V, Oliveri M, Romeo M, Berretta M, Rossi P. A New Proposal for the Pathogenic Mechanism of Non-Coeliac/Non-Allergic Gluten/Wheat Sensitivity: Piecing Together the Puzzle of Recent Scientific Evidence. Nutrients 2017;9:E1203. [PMID: 29099090 DOI: 10.3390/nu9111203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
35 Casado-Bedmar M, Keita ÅV. Potential neuro-immune therapeutic targets in irritable bowel syndrome. Therap Adv Gastroenterol 2020;13:1756284820910630. [PMID: 32313554 DOI: 10.1177/1756284820910630] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1:36-42. [PMID: 22053295 DOI: 10.5415/apallergy.2011.1.1] [Reference Citation Analysis]
37 Bokic T, Storr M, Schicho R. Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview. Pharmacology. 2015;96:76-85. [PMID: 26139425 DOI: 10.1159/000435816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
38 Mass E, Gentek R. Fetal-Derived Immune Cells at the Roots of Lifelong Pathophysiology. Front Cell Dev Biol 2021;9:648313. [PMID: 33708774 DOI: 10.3389/fcell.2021.648313] [Reference Citation Analysis]
39 Pierce AN, Christianson JA. Stress and Chronic Pelvic Pain. Molecular and Cell Biology of Pain. Elsevier; 2015. pp. 509-35. [DOI: 10.1016/bs.pmbts.2014.11.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
40 van Hoboken EA, Thijssen AY, Verhaaren R, van der Veek PP, Prins FA, Verspaget HW, Masclee AA. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity. Scand J Gastroenterol. 2011;46:981-987. [PMID: 21623672 DOI: 10.3109/00365521.2011.579156] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
41 Katiraei P, Bultron G. Need for a comprehensive medical approach to the neuro-immuno-gastroenterology of irritable bowel syndrome. World J Gastroenterol. 2011;17:2791-2800. [PMID: 21734786 DOI: 10.3748/wjg.v17.i23.2791] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Marasco G, Lenti MV, Cremon C, Barbaro MR, Stanghellini V, Di Sabatino A, Barbara G. Implications of SARS-CoV-2 infection for neurogastroenterology.Neurogastroenterol Motil. 2021;33:e14104. [PMID: 33591607 DOI: 10.1111/nmo.14104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
43 Kennedy PJ, Clarke G, O‘Neill A, Groeger JA, Quigley EMM, Shanahan F, Cryan JF, Dinan TG. Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory. Psycholog Med. 2013;FirstView:1-14. [PMID: 23985155 DOI: 10.1017/s0033291713002171] [Cited by in Crossref: 58] [Cited by in F6Publishing: 28] [Article Influence: 7.3] [Reference Citation Analysis]
44 Chey WD, Shah ED, DuPont HL. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therap Adv Gastroenterol 2020;13:1756284819897531. [PMID: 32047534 DOI: 10.1177/1756284819897531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
45 Lee JW, Park JH, Park DIL, Park J, Kim HJ, Cho YK, Sohn CIL, Jeon WK, Kim BI. Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase. Dig Dis Sci 2010;55:2922-8. [DOI: 10.1007/s10620-009-1094-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
46 Wang T, Li L, Li S, Zhao H, Qu J, Xia Y, Li Y. Clostridium butyricum relieve the visceral hypersensitivity in mice induced by Citrobacter rodentium infection with chronic stress. PeerJ 2021;9:e11585. [PMID: 34221718 DOI: 10.7717/peerj.11585] [Reference Citation Analysis]
47 Hasenoehrl C, Taschler U, Storr M, Schicho R. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterol Motil 2016;28:1765-80. [PMID: 27561826 DOI: 10.1111/nmo.12931] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 11.6] [Reference Citation Analysis]
48 Gebhardt T, Lorentz A, Detmer F, Trautwein C, Bektas H, Manns MP, Bischoff SC. Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1. Gut 2005;54:928-34. [PMID: 15951536 DOI: 10.1136/gut.2004.054650] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
49 Albert-Bayo M, Paracuellos I, González-Castro AM, Rodríguez-Urrutia A, Rodríguez-Lagunas MJ, Alonso-Cotoner C, Santos J, Vicario M. Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis. Cells 2019;8:E135. [PMID: 30744042 DOI: 10.3390/cells8020135] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 26.0] [Reference Citation Analysis]
50 Zeng J, Li YQ, Zuo XL, Zhen YB, Yang J, Liu CH. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28:994-1002. [PMID: 18671775 DOI: 10.1111/j.1365-2036.2008.03818.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 9.3] [Reference Citation Analysis]
51 Bellini M, Gambaccini D, Stasi C, Urbano MT, Marchi S, Usai-Satta P. Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol. 2014;20:8807-8820. [PMID: 25083055 DOI: 10.3748/wjg.v20.i27.8807] [Cited by in F6Publishing: 27] [Reference Citation Analysis]
52 Kayssi A, Amadesi S, Bautista F, Bunnett NW, Vanner S. Mechanisms of protease-activated receptor 2-evoked hyperexcitability of nociceptive neurons innervating the mouse colon. J Physiol. 2007;580:977-991. [PMID: 17289784 DOI: 10.1113/jphysiol.2006.126599] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
53 Levy D, Burstein R, Strassman AM. Mast Cell Involvement in the Pathophysiology of Migraine Headache: A Hypothesis. Headache 2006;46:S13-8. [DOI: 10.1111/j.1526-4610.2006.00485.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
54 Hillsley K, Lin JH, Stanisz A, Grundy D, Aerssens J, Peeters PJ, Moechars D, Coulie B, Stead RH. Dissecting the role of sodium currents in visceral sensory neurons in a model of chronic hyperexcitability using Nav1.8 and Nav1.9 null mice. J Physiol 2006;576:257-67. [PMID: 16857712 DOI: 10.1113/jphysiol.2006.113597] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 3.5] [Reference Citation Analysis]
55 Osborne S, Farrell J, Dearman RJ, MacIver K, Naisbitt DJ, Moots RJ, Edwards SW, Goebel A. Cutaneous immunopathology of long-standing complex regional pain syndrome. Eur J Pain 2015;19:1516-26. [PMID: 25728589 DOI: 10.1002/ejp.685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
56 Stanghellini V, Barbara G, Cremon C, Cogliandro R, Antonucci A, Gabusi V, Frisoni C, De Giorgio R, Grasso V, Serra M. Gut microbiota and related diseases: clinical features. Intern Emerg Med. 2010;5 Suppl 1:S57-S63. [PMID: 20865476 DOI: 10.1007/s11739-010-0451-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
57 Berdún S, Rychter J, Vergara P. Surgical intestinal manipulation increases gene expression of TrkA, CGRP, and PAR-2 IN dorsal root ganglia in the rat. Neurogastroenterol Motil 2016;28:816-26. [PMID: 26909771 DOI: 10.1111/nmo.12777] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
58 Hagel AF, deRossi T, Zopf Y, Konturek P, Dauth W, Kressel J, Hahn EG, Raithel M. Mast cell tryptase levels in gut mucosa in patients with gastrointestinal symptoms caused by food allergy. Int Arch Allergy Immunol 2013;160:350-5. [PMID: 23183101 DOI: 10.1159/000341634] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
59 Neree AT, Soret R, Marcocci L, Pietrangeli P, Pilon N, Mateescu MA. Vegetal diamine oxidase alleviates histamine-induced contraction of colonic muscles. Sci Rep 2020;10:21563. [PMID: 33299054 DOI: 10.1038/s41598-020-78134-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Collins SM, Chang C, Mearin F. Postinfectious Chronic Gut Dysfunction: From Bench to Bedside. Am J Gastroenterol Suppl 2012;1:2-8. [DOI: 10.1038/ajgsup.2012.2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
61 Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312:G52-G62. [PMID: 27881403 DOI: 10.1152/ajpgi.00338.2016] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 15.0] [Reference Citation Analysis]
62 Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G. Mucosal immune activation in irritable bowel syndrome: Gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009;104:392-400. [PMID: 19174797 DOI: 10.1038/ajg.2008.94] [Cited by in Crossref: 222] [Cited by in F6Publishing: 217] [Article Influence: 18.5] [Reference Citation Analysis]
63 Chang L, Adeyemo M, Karagiannides I, Videlock EJ, Bowe C, Shih W, Presson AP, Yuan PQ, Cortina G, Gong H. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol. 2012;107:262-272. [PMID: 22158028 DOI: 10.1038/ajg.2011.423] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 9.8] [Reference Citation Analysis]
64 Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, Algül H, Friess H, Ceyhan GO. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One. 2013;8:e60529. [PMID: 23555989 DOI: 10.1371/journal.pone.0060529] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
65 Ford AC, Talley NJ, Walker MM, Jones MP. Increased prevalence of autoimmune diseases in functional gastrointestinal disorders: Case-control study of 23471 primary care patients. Aliment Pharmacol Ther. 2014;40:827-834. [PMID: 25131320 DOI: 10.1111/apt.12903] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
66 Quigley EM. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis. 2007;8:2-7. [PMID: 17261128 DOI: 10.1111/j.1443-9573.2007.00277.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
67 Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut. 2008;57:923-929. [PMID: 18252749 DOI: 10.1136/gut.2007.138982] [Cited by in Crossref: 316] [Cited by in F6Publishing: 276] [Article Influence: 24.3] [Reference Citation Analysis]
68 Bai J, Khaldi S, Gargala G, Baishanbo A, François A, Ballet JJ, Ducrotté P, Fioramonti J, Favennec L, Le Goff L. Effects of octreotide on jejunal hypersensitivity triggered by Cryptosporidium parvum intestinal infection in an immunocompetent suckling rat model. Neurogastroenterol Motil 2011;23:1043-50, e499. [PMID: 21320238 DOI: 10.1111/j.1365-2982.2011.01680.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
69 Kraneveld AD, Rijnierse A, Nijkamp FP, Garssen J. Neuro-immune interactions in inflammatory bowel disease and irritable bowel syndrome: future therapeutic targets. Eur J Pharmacol. 2008;585:361-374. [PMID: 18417115 DOI: 10.1016/j.ejphar.2008.02.095] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
70 Kimura T, Amano T, Uehara H, Ariga H, Ishida T, Torii A, Tajiri H, Matsueda K, Yamato S. Urocortin I is present in the enteric nervous system and exerts an excitatory effect via cholinergic and serotonergic pathways in the rat colon. Am J Physiol Gastrointest Liver Physiol. 2007;293:G903-G910. [PMID: 17717045 DOI: 10.1152/ajpgi.00066.2007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
71 Kalliomäki MA. Food allergy and irritable bowel syndrome. Curr Opin Gastroenterol 2005;21:708-11. [PMID: 16220050 DOI: 10.1097/01.mog.0000181712.81657.0a] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
72 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
73 Liebregts T, Adam B, Bredack C, Gururatsakul M, Pilkington KR, Brierley SM, Blackshaw LA, Gerken G, Talley NJ, Holtmann G. Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. Am J Gastroenterol. 2011;106:1089-1098. [PMID: 21245834 DOI: 10.1038/ajg.2010.512] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 10.1] [Reference Citation Analysis]
74 Goebel A. Immunoglobulin Responsive Chronic Pain. J Clin Immunol 2010;30:103-8. [DOI: 10.1007/s10875-010-9403-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
75 Chen Y, Cheng J, Zhang Y, Chen JDZ, Seralu FM. Electroacupuncture at ST36 Relieves Visceral Hypersensitivity via the NGF/TrkA/TRPV1 Peripheral Afferent Pathway in a Rodent Model of Post-Inflammation Rectal Hypersensitivity. J Inflamm Res 2021;14:325-39. [PMID: 33584100 DOI: 10.2147/JIR.S285146] [Reference Citation Analysis]
76 Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2019;25:269-281. [PMID: 30670915 DOI: 10.3748/wjg.v25.i2.269] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
77 Saito T, Bunnett NW. Protease-activated receptors: regulation of neuronal function. Neuromolecular Med. 2005;7:79-99. [PMID: 16052040 DOI: 10.1385/nmm:7:1-2:079] [Cited by in Crossref: 37] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
78 Sun S, Liu W, Li Y. CADM1 enhances intestinal barrier function in a rat model of mild inflammatory bowel disease by inhibiting the STAT3 signaling pathway. J Bioenerg Biomembr 2020;52:343-54. [PMID: 32929607 DOI: 10.1007/s10863-020-09850-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
79 Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol. 2007;42 Suppl 17:41-47. [PMID: 17238025 DOI: 10.1007/s00535-006-1925-8] [Cited by in Crossref: 122] [Cited by in F6Publishing: 108] [Article Influence: 8.7] [Reference Citation Analysis]
80 Balestra B, Vicini R, Cremon C, Zecchi L, Dothel G, Vasina V, De Giorgio R, Paccapelo A, Pastoris O, Stanghellini V. Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons. Neurogastroenterol Motil. 2012;24:e1118-e1570. [PMID: 22937879 DOI: 10.1111/nmo.12000] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
81 Tikoo S, Barki N, Jain R, Zulkhernain NS, Buhner S, Schemann M, Weninger W. Imaging of mast cells. Immunol Rev 2018;282:58-72. [PMID: 29431206 DOI: 10.1111/imr.12631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
82 spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil 2006;18:1045-55. [DOI: 10.1111/j.1365-2982.2006.00836.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
83 Tan TK, Chen AC, Lin CL, Shen TC, Li TC, Wei CC. Preschoolers With Allergic Diseases Have an Increased Risk of Irritable Bowel Syndrome When Reaching School Age. J Pediatr Gastroenterol Nutr. 2017;64:26-30. [PMID: 27035379 DOI: 10.1097/mpg.0000000000001219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
84 Agostini S, Goubern M, Tondereau V, Salvador-Cartier C, Bezirard V, Lévèque M, Keränen H, Theodorou V, Bourdu-Naturel S, Goupil-Feuillerat N. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats. Neurogastroenterol Motil. 2012;24:376-e172. [PMID: 22272920 DOI: 10.1111/j.1365-2982.2011.01865.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
85 Bortolotti M, Porta S. Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci. 2011;56:3288-3295. [PMID: 21573941 DOI: 10.1007/s10620-011-1740-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
86 Weinstock LB, Rezaie A, Afrin LB. The Significance of Mast Cell Activation in the Era of Precision Medicine. Am J Gastroenterol. 2018;113:1725-1726. [PMID: 30349067 DOI: 10.1038/s41395-018-0257-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Schäppi MG, Borrelli O, Knafelz D, Williams S, Smith VV, Milla PJ, Lindley KJ. Mast cell-nerve interactions in children with functional dyspepsia. J Pediatr Gastroenterol Nutr. 2008;47:472-480. [PMID: 18852640 DOI: 10.1097/mpg.0b013e318186008e] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
88 Adam B, Liebregts T, Gschossmann JM, Krippner C, Scholl F, Ruwe M, Holtmann G. Severity of mucosal inflammation as a predictor for alterations of visceral sensory function in a rat model. Pain. 2006;123:179-186. [PMID: 16630696 DOI: 10.1016/j.pain.2006.02.029] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
89 Walker MM, Talley NJ. Functional gastrointestinal disorders and the potential role of eosinophils. Gastroenterol Clin North Am. 2008;37:383-395, vi. [PMID: 18499026 DOI: 10.1016/j.gtc.2008.02.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
90 Brookes S, Chen N, Humenick A, Spencer NJ, Costa M. Extrinsic Sensory Innervation of the Gut: Structure and Function. In: Brierley S, Costa M, editors. The Enteric Nervous System. Cham: Springer International Publishing; 2016. pp. 63-9. [DOI: 10.1007/978-3-319-27592-5_7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
91 Mozaffari S, Esmaily H, Rahimi R, Baeeri M, Sanei Y, Asadi-Shahmirzadi A, Salehi-Surmaghi MH, Abdollahi M. Effects of Hypericum perforatum extract on rat irritable bowel syndrome. Pharmacogn Mag. 2011;7:213-223. [PMID: 21969792 DOI: 10.4103/0973-1296] [Reference Citation Analysis]
92 Lazaraki G, Chatzimavroudis G, Katsinelos P. Recent advances in pharmacological treatment of irritable bowel syndrome. World J Gastroenterol. 2014;20:8867-8885. [PMID: 25083060 DOI: 10.3748/wjg.v20.i27.8867] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
93 Buhner S, Braak B, Li Q, Kugler EM, Klooker T, Wouters M, Donovan J, Vignali S, Mazzuoli-weber G, Grundy D, Boeckxstaens G, Schemann M. Neuronal activation by mucosal biopsy supernatants from irritable bowel syndrome patients is linked to visceral sensitivity: Neuronal activation in irritable bowel syndrome. Exp Physiol 2014;99:1299-311. [DOI: 10.1113/expphysiol.2014.080036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
94 Martins PR, Nascimento RD, Dos Santos AT, de Oliveira EC, Martinelli PM, d'Avila Reis D. Mast cell-nerve interaction in the colon of Trypanosoma cruzi-infected individuals with chagasic megacolon. Parasitol Res 2018;117:1147-58. [PMID: 29470711 DOI: 10.1007/s00436-018-5792-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 El-Salhy M, Hatlebakk JG, Gilja OH, Hausken T. Irritable bowel syndrome: recent developments in diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol Hepatol. 2014;8:435-443. [PMID: 24580043 DOI: 10.1586/17474124.2014.888952] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
96 Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55:716-723. [PMID: 19255843 DOI: 10.1007/s10620-009-0765-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
97 Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76. [PMID: 22730468 DOI: 10.1136/gutjnl-2012-302167] [Cited by in Crossref: 513] [Cited by in F6Publishing: 428] [Article Influence: 57.0] [Reference Citation Analysis]
98 Talley NJ. Decade in review-FGIDs: 'Functional' gastrointestinal disorders-a paradigm shift. Nat Rev Gastroenterol Hepatol. 2014;11:649-650. [PMID: 25245015 DOI: 10.1038/nrgastro.2014.163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
99 Li ZY, Zhang N, Wen S, Zhang J, Sun XL, Fan XM, Sun YH. Decreased glucagon-like peptide-1 correlates with abdominal pain in patients with constipation-predominant irritable bowel syndrome. Clin Res Hepatol Gastroenterol. 2017; Epub ahead of print. [PMID: 28215540 DOI: 10.1016/j.clinre.2016.12.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
100 Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut. 2006;55:655-661. [PMID: 16299034 DOI: 10.1136/gut.2005.078675] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 5.0] [Reference Citation Analysis]
101 Cuevas M, Flores I, Thompson KJ, Ramos-Ortolaza DL, Torres-Reveron A, Appleyard CB. Stress exacerbates endometriosis manifestations and inflammatory parameters in an animal model. Reprod Sci 2012;19:851-62. [PMID: 22527982 DOI: 10.1177/1933719112438443] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
102 Hubball A, Martin JE, Lang B, De Giorgio R, Knowles CH. The role of humoral autoimmunity in gastrointestinal neuromuscular diseases. Prog Neurobiol 2009;87:10-20. [PMID: 18929621 DOI: 10.1016/j.pneurobio.2008.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
103 Ekiz Ö, Balta I, Özuğuz P, Şen BB, Rifaioğlu EN, Ekiz F, Yüksel I, Coban Ş, Başar Ö. Irritable bowel syndrome in patients with chronic pruritus of undetermined origin. J Eur Acad Dermatol Venereol 2014;28:1034-9. [PMID: 24033408 DOI: 10.1111/jdv.12251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
104 Guarino MP, Barbara G, Cicenia A, Altomare A, Barbaro MR, Cocca S, Scirocco A, Cremon C, Emerenziani S, Stanghellini V. Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility. Neurogastroenterol Motil. 2017;29. [PMID: 27619727 DOI: 10.1111/nmo.12928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
105 Barbara G, Cremon C, Stanghellini V. Inflammatory bowel disease and irritable bowel syndrome: similarities and differences. Curr Opin Gastroenterol. 2014;30:352-358. [PMID: 24811054 DOI: 10.1097/mog.0000000000000070] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
106 Burns AJ, Thapar N. Developmental and Postnatal Changes in the Enteric Nervous System. Journal of Pediatric Gastroenterology & Nutrition 2013;57:S4-8. [DOI: 10.1097/01.mpg.0000441925.75189.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
107 Lieu T, Savage E, Zhao P, Edgington-Mitchell L, Barlow N, Bron R, Poole DP, McLean P, Lohman RJ, Fairlie DP, Bunnett NW. Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2. Br J Pharmacol 2016;173:2752-65. [PMID: 27423137 DOI: 10.1111/bph.13554] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
108 Boulete IM, Thadi A, Beaufrand C, Patwa V, Joshi A, Foss JA, Eddy EP, Eutamene H, Palejwala VA, Theodorou V, Shailubhai K. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol 2018;24:1888-900. [PMID: 29740204 DOI: 10.3748/wjg.v24.i17.1888] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
109 Buhner S, Li Q, Berger T, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Schemann M. Submucous rather than myenteric neurons are activated by mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil. 2012;24:e1134-e1572. [PMID: 22963673 DOI: 10.1111/nmo.12011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
110 Sarker P, Bhuiyan TR, Qadri F, Alam NH, Wretlind B, Bishop AE, Mathan M, Agerberth B, Andersson J, Raqib R. Differential expression of enteric neuroimmune-network in invasive and acute watery diarrhoea. Neurogastroenterol Motil 2010;22:70-8, e29. [PMID: 19650770 DOI: 10.1111/j.1365-2982.2009.01375.x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
111 Chang JY, Talley NJ. An update on irritable bowel syndrome: from diagnosis to emerging therapies. Curr Opin Gastroenterol. 2011;27:72-78. [PMID: 21099429 DOI: 10.1097/mog.0b013e3283414065] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
112 Arebi N, Gurmany S, Bullas D, Hobson A, Stagg A, Kamm M. Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther. 2008;28:830-840. [PMID: 18637004 DOI: 10.1111/j.1365-2036.2008.03801.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
113 Bischoff SC, Krämer S. Human mast cells, bacteria, and intestinal immunity. Immunol Rev 2007;217:329-37. [DOI: 10.1111/j.1600-065x.2007.00523.x] [Cited by in Crossref: 100] [Cited by in F6Publishing: 36] [Article Influence: 7.1] [Reference Citation Analysis]
114 Park BK, Chun E, Choi JJ, Shin Y, Kho YT, Oh SH, Kim SY, Lee TH, Kim TW, Shin E, Do SG, Jin M. Administration of Wasabia koreana Ameliorates Irritable Bowel Syndrome-Like Symptoms in a Zymosan-Induced Mouse Model. J Med Food 2017;20:474-84. [PMID: 28452565 DOI: 10.1089/jmf.2016.3844] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
115 Xu XJ, Liu L, Yao SK. Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B. 2016;17:1-9. [PMID: 26739521 DOI: 10.1631/jzus.b1500181] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
116 Choi K, Chen J, Mitra S, Sarna SK. Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle. Gastroenterology. 2011;141:1293-1301, 1301.e1-3. [PMID: 21745450 DOI: 10.1053/j.gastro.2011.06.074] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
117 Enck P, Aziz Q, Barbara G, Farmer AD, Fukudo S, Mayer EA, Niesler B, Quigley EM, Rajilić-Stojanović M, Schemann M, Schwille-Kiuntke J, Simren M, Zipfel S, Spiller RC. Irritable bowel syndrome. Nat Rev Dis Primers 2016;2:16014. [PMID: 27159638 DOI: 10.1038/nrdp.2016.14] [Cited by in Crossref: 338] [Cited by in F6Publishing: 252] [Article Influence: 67.6] [Reference Citation Analysis]
118 Bischoff SC. Mast cells in gastrointestinal disorders. European Journal of Pharmacology 2016;778:139-45. [DOI: 10.1016/j.ejphar.2016.02.018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 8.2] [Reference Citation Analysis]
119 Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381-396. [PMID: 21090962 DOI: 10.1146/annurev-med-012309-103958] [Cited by in Crossref: 275] [Cited by in F6Publishing: 225] [Article Influence: 27.5] [Reference Citation Analysis]
120 Cheng L, Luo QQ, Chen SL. The role of intestinal mast cell infiltration in irritable bowel syndrome. J Dig Dis 2021;22:143-51. [PMID: 33511763 DOI: 10.1111/1751-2980.12971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7:48-53. [PMID: 18848909 DOI: 10.1016/j.cgh.2008.08.032] [Cited by in Crossref: 81] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
122 Alonso C, Santos J. Editorial: A Closer Look at Mucosal Inflammation in Irritable Bowel Syndrome: Sex- and Gender-Related Disparities—Quantity, Quality, or Both? Am J Gastroenterol 2009;104:401-3. [DOI: 10.1038/ajg.2008.105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
123 Friesen CA, Sandridge L, Andre L, Roberts CC, Abdel-Rahman SM. Mucosal eosinophilia and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila). 2006;45:143-147. [PMID: 16528434 DOI: 10.1177/000992280604500205] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
124 Thomas LV, Ockhuizen T. New insights into the impact of the intestinal microbiota on health and disease: a symposium report. Br J Nutr 2012;107:S1-S13. [DOI: 10.1017/s0007114511006970] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
125 Róka R, Demaude J, Cenac N, Ferrier L, Salvador-Cartier C, Garcia-Villar R, Fioramonti J, Bueno L. Colonic luminal proteases activate colonocyte proteinase-activated receptor-2 and regulate paracellular permeability in mice. Neurogastroenterol Motil. 2007;19:57-65. [PMID: 17187589 DOI: 10.1111/j.1365-2982.2006.00851.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
126 Lomax AE, Pradhananga S, Sessenwein JL, O'Malley D. Bacterial modulation of visceral sensation: mediators and mechanisms. Am J Physiol Gastrointest Liver Physiol 2019;317:G363-72. [PMID: 31290688 DOI: 10.1152/ajpgi.00052.2019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
127 Zhu H, Liu Y, Chen S, Wang X, Pi D, Leng W, Chen F, Zhang J, Kang P. Fish oil enhances intestinal barrier function and inhibits corticotropin-releasing hormone/corticotropin-releasing hormone receptor 1 signalling pathway in weaned pigs after lipopolysaccharide challenge. Br J Nutr 2016;115:1947-57. [PMID: 27080003 DOI: 10.1017/S0007114516001100] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
128 Christianson JA, Bielefeldt K, Altier C, Cenac N, Davis BM, Gebhart GF, High KW, Kollarik M, Randich A, Undem B. Development, plasticity and modulation of visceral afferents. Brain Res Rev. 2009;60:171-186. [PMID: 19150371 DOI: 10.1016/j.brainresrev.2008.12.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.5] [Reference Citation Analysis]
129 Dorofeyev AE, Kiriyan EA, Vasilenko IV, Rassokhina OA, Elin AF. Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome. Clin Exp Gastroenterol. 2011;4:141-153. [PMID: 21753896 DOI: 10.21471/CEG.S18381] [Reference Citation Analysis]
130 Loewendorf AI, Matynia A, Saribekyan H, Gross N, Csete M, Harrington M. Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Front Immunol 2016;7:140. [PMID: 27148260 DOI: 10.3389/fimmu.2016.00140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
131 Mearin F, Perelló A, Balboa A. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?]. Gastroenterol Hepatol. 2009;32:364-372. [PMID: 19442413 DOI: 10.1016/j.gastrohep.2008.12.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
132 Wang GD, Wang XY, Hu HZ, Fang XC, Liu S, Gao N, Xia Y, Wood JD. Angiotensin receptors and actions in guinea pig enteric nervous system. Am J Physiol Gastrointest Liver Physiol. 2005;289:G614-G626. [PMID: 16093423 DOI: 10.1152/ajpgi.00119.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
133 Wang XJ, Carlson P, Chedid V, Maselli DB, Taylor AL, McKinzie S, Camilleri M. Differential mRNA Expression in Ileal Mucosal Biopsies of Patients With Diarrhea- or Constipation-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol 2021;12:e00329. [PMID: 33843785 DOI: 10.14309/ctg.0000000000000329] [Reference Citation Analysis]
134 Jones MP, Chey WD, Singh S, Gong H, Shringarpure R, Hoe N, Chuang E, Talley NJ. A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads. Aliment Pharmacol Ther 2014;39:426-37. [DOI: 10.1111/apt.12608] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
135 Prins A. The brain-gut interaction: the conversation and the implications. South African Journal of Clinical Nutrition 2016;24:8-14. [DOI: 10.1080/16070658.2011.11734373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
136 Barbaro MR, Cremon C, Fuschi D, Scaioli E, Veneziano A, Marasco G, Festi D, Stanghellini V, Barbara G. Nerve fiber overgrowth in patients with symptomatic diverticular disease. Neurogastroenterol Motil 2019;31:e13575. [PMID: 30838745 DOI: 10.1111/nmo.13575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Shen B, Sanmiguel C, Bennett AE, Lian L, Larive B, Remzi FH, Fazio VW, Soffer EE. Irritable pouch syndrome is characterized by visceral hypersensitivity: . Inflammatory Bowel Diseases 2011;17:994-1002. [DOI: 10.1002/ibd.21412] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
138 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
139 Jardí F, Martínez V, Vergara P. NGF is involved in oral ovalbumin-induced altered colonic contractility in rats: evidence from the blockade of TrkA receptors with K252a. Neurogastroenterol Motil. 2012;24:e580-e590. [PMID: 23072452 DOI: 10.1111/nmo.12027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Russo G, Caliendo G, Santagada V, Cirino G, Wallace JL, Fiorucci S. 5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. J Pharmacol Exp Ther 2006;319:447-58. [PMID: 16855178 DOI: 10.1124/jpet.106.106435] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 6.6] [Reference Citation Analysis]
141 Graziottin A, Skaper SD, Fusco M. Mast cells in chronic inflammation, pelvic pain and depression in women. Gynecol Endocrinol 2014;30:472-7. [PMID: 24811097 DOI: 10.3109/09513590.2014.911280] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
142 Fan L, Wong M, Fan XS, Hong Y, Sun K, Jiang C, Xie X, Wang HL. Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission. J Clin Gastroenterol 2021;55:244-9. [PMID: 32649443 DOI: 10.1097/MCG.0000000000001394] [Reference Citation Analysis]
143 Brun P, Scarpa M, Marchiori C, Sarasin G, Caputi V, Porzionato A, Giron MC, Palù G, Castagliuolo I. Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One 2017;12:e0181863. [PMID: 28732069 DOI: 10.1371/journal.pone.0181863] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
144 Uranga JA, Martínez V, Abalo R. Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use. Molecules 2020;25:E4314. [PMID: 32962285 DOI: 10.3390/molecules25184314] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
145 Teruel C, Garrido E, Mesonero F. Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther. 2016;7:78-90. [PMID: 26855814 DOI: 10.4292/wjgpt.v7.i1.78] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
146 Castro J, Harrington AM, Garcia-Caraballo S, Maddern J, Grundy L, Zhang J, Page G, Miller PE, Craik DJ, Adams DJ, Brierley SM. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors. Gut 2017;66:1083-94. [PMID: 26887818 DOI: 10.1136/gutjnl-2015-310971] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
147 Miranda A. Early life events and the development of visceral hyperalgesia. J Pediatr Gastroenterol Nutr. 2008;47:682-684. [PMID: 18955876 DOI: 10.1097/01.mpg.0000338958.94313.99] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
148 Rauhavirta T, Lindfors K, Koskinen O, Laurila K, Kurppa K, Saavalainen P, Mäki M, Collin P, Kaukinen K. Impaired epithelial integrity in the duodenal mucosa in early stages of celiac disease. Translational Research 2014;164:223-31. [DOI: 10.1016/j.trsl.2014.02.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
149 Berdún S, Bombuy E, Estrada O, Mans E, Rychter J, Clavé P, Vergara P. Peritoneal mast cell degranulation and gastrointestinal recovery in patients undergoing colorectal surgery. Neurogastroenterol Motil 2015;27:764-74. [DOI: 10.1111/nmo.12525] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
150 Zhang L, Song J, Bai T, Wang R, Hou X. Sustained pain hypersensitivity in the stressed colon: Role of mast cell-derived nerve growth factor-mediated enteric synaptic plasticity. Neurogastroenterol Motil 2018;30:e13430. [DOI: 10.1111/nmo.13430] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
151 Xu X, Li Z, Zou D, Yang M, Liu Z, Wang X. High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease. Dig Dis Sci. 2013;58:53-60. [PMID: 22961239 DOI: 10.1007/s10620-012-2308-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
152 Le Nevé B, Posserud I, Böhn L, Guyonnet D, Rondeau P, Tillisch K, Naliboff B, Mayer EA, Simrén M. A Combined Nutrient and Lactulose Challenge Test Allows Symptom-Based Clustering of Patients With Irritable Bowel Syndrome. American Journal of Gastroenterology 2013;108:786-95. [DOI: 10.1038/ajg.2013.75] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
153 Ivison SM, Steiner TS. Anti-flagellin antibodies in irritable bowel syndrome: another attack on our commensals? Neurogastroenterol Motil 2008;20:1081-5. [PMID: 18826558 DOI: 10.1111/j.1365-2982.2008.01199.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
154 Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol. 2008;100:49-53. [PMID: 18254482 DOI: 10.1016/s1081-1206(10)60404-8] [Cited by in Crossref: 56] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
155 Ringel Y. The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders. Gastroenterology Clinics of North America 2017;46:91-101. [DOI: 10.1016/j.gtc.2016.09.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
156 Bennet SMP, Sundin J, Magnusson MK, Strid H, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L. Altered intestinal antibacterial gene expression response profile in irritable bowel syndrome is linked to bacterial composition and immune activation. Neurogastroenterol Motil 2018;30:e13468. [PMID: 30230134 DOI: 10.1111/nmo.13468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
157 Borrelli O, Barbara G, Di Nardo G, Cremon C, Lucarelli S, Frediani T, Paganelli M, De Giorgio R, Stanghellini V, Cucchiara S. Neuroimmune Interaction and Anorectal Motility in Children With Food Allergy-Related Chronic Constipation. Am J Gastroenterol 2009;104:454-63. [DOI: 10.1038/ajg.2008.109] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
158 Breunig E, Michel K, Zeller F, Seidl S, Weyhern CW, Schemann M. Histamine excites neurones in the human submucous plexus through activation of H1, H2, H3 and H4 receptors. J Physiol. 2007;583:731-742. [PMID: 17627982 DOI: 10.1113/jphysiol.2007.139352] [Cited by in Crossref: 95] [Cited by in F6Publishing: 86] [Article Influence: 6.8] [Reference Citation Analysis]
159 Wang GD, Wang XY, Zou F, Qu M, Liu S, Fei G, Xia Y, Needleman BJ, Mikami DJ, Wood JD. Mast cell expression of the serotonin1A receptor in guinea pig and human intestine. Am J Physiol Gastrointest Liver Physiol 2013;304:G855-63. [PMID: 23518679 DOI: 10.1152/ajpgi.00421.2012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
160 Adeyemo MA, Spiegel BM, Chang L. Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther. 2010;32:738-755. [PMID: 20662786 DOI: 10.1111/j.1365-2036.2010.04409.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 77] [Article Influence: 8.0] [Reference Citation Analysis]
161 Edgington-Mitchell LE. Pathophysiological roles of proteases in gastrointestinal disease. Am J Physiol Gastrointest Liver Physiol. 2016;310:G234-G239. [PMID: 26702140 DOI: 10.1152/ajpgi.00393.2015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
162 Camilleri M, Gorman H. Intestinal permeability and irritable bowel syndrome. Neurogastroenterol Motil. 2007;19:545-552. [PMID: 17593135 DOI: 10.1111/j.1365-2982.2007.00925.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 91] [Article Influence: 6.8] [Reference Citation Analysis]
163 Balmus IM, Ciobica A, Cojocariu R, Luca AC, Gorgan L. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas) 2020;56:E175. [PMID: 32295083 DOI: 10.3390/medicina56040175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
164 O’malley D, Quigley EM, Dinan TG, Cryan JF. Do interactions between stress and immune responses lead to symptom exacerbations in irritable bowel syndrome? Brain, Behavior, and Immunity 2011;25:1333-41. [DOI: 10.1016/j.bbi.2011.04.009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
165 McCullough R, McCullough J. Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop. Transl Gastroenterol Hepatol 2017;2:18. [PMID: 28447053 DOI: 10.21037/tgh.2017.03.02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
166 Walker MM, Warwick A, Ung C, Talley NJ. The role of eosinophils and mast cells in intestinal functional disease. Curr Gastroenterol Rep. 2011;13:323-330. [PMID: 21552990 DOI: 10.1007/s11894-011-0197-5] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
167 Padhy SK, Sahoo S, Mahajan S, Sinha SK. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract 2015;6:568-77. [PMID: 26752904 DOI: 10.4103/0976-3147.169802] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
168 Jiménez M, Cervantes-García D, Córdova-Dávalos LE, Pérez-Rodríguez MJ, Gonzalez-Espinosa C, Salinas E. Responses of Mast Cells to Pathogens: Beneficial and Detrimental Roles. Front Immunol 2021;12:685865. [PMID: 34211473 DOI: 10.3389/fimmu.2021.685865] [Reference Citation Analysis]
169 Carroll SY, O’Mahony SM, Grenham S, Cryan JF, Hyland NP. Disodium cromoglycate reverses colonic visceral hypersensitivity and influences colonic ion transport in a stress-sensitive rat strain. PLoS One. 2013;8:e84718. [PMID: 24367692 DOI: 10.1371/journal.pone.0084718] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
170 O’Malley D, Buckley MM, McKernan DP, Quigley EM, Cryan JF, Dinan TG. Soluble mediators in plasma from irritable bowel syndrome patients excite rat submucosal neurons. Brain Behav Immun. 2015;44:57-67. [PMID: 25150006 DOI: 10.1016/j.bbi.2014.08.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
171 Hamilton MJ, Zhao M, Giannetti MP, Weller E, Hufdhi R, Novak P, Mendoza-Alvarez LB, Hornick J, Lyons JJ, Glover SC, Castells MC, Pozdnyakova O. Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome. Am J Surg Pathol 2021;45:997-1004. [PMID: 33481382 DOI: 10.1097/PAS.0000000000001676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
172 Arshi J, Layfield LJ, Esebua M. Mast cell infiltration and activation in the gallbladder wall: Implications for the pathogenesis of functional gallbladder disorder in adult patients. Ann Diagn Pathol 2021;54:151798. [PMID: 34391170 DOI: 10.1016/j.anndiagpath.2021.151798] [Reference Citation Analysis]
173 Barratt HS, Kalantzis C, Polymeros D, Forbes A. Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status. Aliment Pharmacol Ther. 2005;21:141-147. [PMID: 15679763 DOI: 10.1111/j.1365-2036.2005.02314.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
174 Ghouzali I, Azhar S, Bôle-feysot C, Ducrotté P, Déchelotte P, Coëffier M. Proteasome inhibitors exacerbate interleukin-8 production induced by protease-activated receptor 2 in intestinal epithelial cells. Cytokine 2016;86:41-6. [DOI: 10.1016/j.cyto.2016.07.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
175 Veldhuis NA, Poole DP, Grace M, Mcintyre P, Bunnett NW, Christopoulos A. The G Protein–Coupled Receptor–Transient Receptor Potential Channel Axis: Molecular Insights for Targeting Disorders of Sensation and Inflammation. Pharmacol Rev 2014;67:36-73. [DOI: 10.1124/pr.114.009555] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 12.7] [Reference Citation Analysis]
176 Piche T. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil. 2014;26:296-302. [PMID: 24548256 DOI: 10.1111/nmo.12315] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 12.1] [Reference Citation Analysis]
177 Bolino CM, Bercik P. Pathogenic factors involved in the development of irritable bowel syndrome: focus on a microbial role. Infect Dis Clin North Am. 2010;24:961-975, ix. [PMID: 20937460 DOI: 10.1016/j.idc.2010.07.005] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
178 Camilleri M, Madsen K, Spiller R, Greenwood-Van Meerveld B, Verne GN. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24:503-512. [PMID: 22583600 DOI: 10.1111/j.1365-2982.2012.01921.x] [Cited by in Crossref: 326] [Cited by in F6Publishing: 284] [Article Influence: 36.2] [Reference Citation Analysis]
179 O' Mahony SM, Coelho AM, Fitzgerald P, Lee K, Winchester W, Dinan TG, Cryan JF. The effects of gabapentin in two animal models of co-morbid anxiety and visceral hypersensitivity. Eur J Pharmacol 2011;667:169-74. [PMID: 21645509 DOI: 10.1016/j.ejphar.2011.05.055] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
180 Khaldi S, Gargala G, Le Goff L, Parey S, Francois A, Fioramonti J, Ballet JJ, Dupont JP, Ducrotté P, Favennec L. Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model. Infect Immun 2009;77:5163-9. [PMID: 19687199 DOI: 10.1128/IAI.00220-09] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
181 Quigley EM. The efficacy of probiotics in IBS. J Clin Gastroenterol 2008;42 Suppl 2:S85-90. [PMID: 18542036 DOI: 10.1097/MCG.0b013e31816244ca] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
182 El-Salhy M. Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome. World J Gastroenterol 2020;26:1427-38. [PMID: 32308344 DOI: 10.3748/wjg.v26.i13.1427] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
183 Bian ZX, Li Z, Huang ZX, Zhang M, Chen HL, Xu HX, Sung JJ. Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients. J Gastroenterol. 2009;44:666-674. [PMID: 19430717 DOI: 10.1007/s00535-009-0058-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
184 Ishimoto H, Oshima T, Sei H, Yamasaki T, Kondo T, Tozawa K, Tomita T, Ohda Y, Fukui H, Watari J, Miwa H. Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients. J Clin Biochem Nutr 2017;60:146-50. [PMID: 28366996 DOI: 10.3164/jcbn.16-92] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
185 Barbaro MR, Cremon C, Morselli-Labate AM, Di Sabatino A, Giuffrida P, Corazza GR, Di Stefano M, Caio G, Latella G, Ciacci C, Fuschi D, Mastroroberto M, Bellacosa L, Stanghellini V, Volta U, Barbara G. Serum zonulin and its diagnostic performance in non-coeliac gluten sensitivity.Gut. 2020;69:1966-1974. [PMID: 32060130 DOI: 10.1136/gutjnl-2019-319281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
186 Shah MK, Wan J, Janyaro H, Tahir AH, Cui L, Ding MX. Visceral Hypersensitivity Is Provoked by 2,4,6-Trinitrobenzene Sulfonic Acid-Induced Ileitis in Rats. Front Pharmacol 2016;7:214. [PMID: 27499743 DOI: 10.3389/fphar.2016.00214] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
187 Fernández-blanco JA, Barbosa S, Sánchez de Medina F, Martínez V, Vergara P. Persistent epithelial barrier alterations in a rat model of postinfectious gut dysfunction: Postinfectious gut barrier dysfunction. Neurogastroenterology & Motility 2011;23:e523-33. [DOI: 10.1111/j.1365-2982.2011.01777.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
188 Lilli NL, Quénéhervé L, Haddara S, Brochard C, Aubert P, Rolli-Derkinderen M, Durand T, Naveilhan P, Hardouin JB, De Giorgio R, Barbara G, Bruley des Varannes S, Coron E, Neunlist M. Glioplasticity in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13232. [PMID: 29027719 DOI: 10.1111/nmo.13232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
189 Annaházi A, Gecse K, Dabek M, Ait-Belgnaoui A, Rosztóczy A, Róka R, Molnár T, Theodorou V, Wittmann T, Bueno L. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice. Pain. 2009;144:209-217. [PMID: 19450926 DOI: 10.1016/j.pain.2009.04.017] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 5.2] [Reference Citation Analysis]
190 Nam Y, Min YS, Sohn UD. Recent advances in pharmacological research on the management of irritable bowel syndrome. Arch Pharm Res 2018;41:955-66. [PMID: 30132170 DOI: 10.1007/s12272-018-1068-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
191 Faure C, Righini Grunder F. Visceral Sensitivity. In: Faure C, Thapar N, Di Lorenzo C, editors. Pediatric Neurogastroenterology. Cham: Springer International Publishing; 2017. pp. 39-52. [DOI: 10.1007/978-3-319-43268-7_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
192 Mujagic Z, Keszthelyi D, Aziz Q, Reinisch W, Quetglas EG, De Leonardis F, Segerdahl M, Masclee AA. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:1064-81. [PMID: 26290286 DOI: 10.1111/apt.13378] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
193 Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil. 2011;17:140-147. [PMID: 21602990 DOI: 10.5056/jnm.2011.17.2.140] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 7.1] [Reference Citation Analysis]
194 Philpott H, Gibson P, Thien F. Irritable bowel syndrome - An inflammatory disease involving mast cells. Asia Pac Allergy. 2011;1:36-42. [PMID: 22053295 DOI: 10.5415/apallergy.2011.1.1.36] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
195 Min T, Ford AC. Efficacy of mesalazine in IBS. Gut. 2016;65:187-188. [PMID: 25873641 DOI: 10.1136/gutjnl-2015-309593] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
196 Almansa C, Agrawal A, Houghton LA. Intestinal microbiota, pathophysiology and translation to probiotic use in patients with irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2012;6:383-398. [PMID: 22646259 DOI: 10.1586/egh.12.9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
197 Li X, Chen H, Lu H, Li W, Chen X, Peng Y, Ge Z. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol. 2010;45:573-581. [PMID: 20163288 DOI: 10.3109/00365521003632576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.3] [Reference Citation Analysis]
198 Barbara G, Wang B, Stanghellini V, de Giorgio R, Cremon C, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology. 2007;132:26-37. [PMID: 17241857 DOI: 10.1053/j.gastro.2006.11.039] [Cited by in Crossref: 484] [Cited by in F6Publishing: 443] [Article Influence: 34.6] [Reference Citation Analysis]
199 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97.] [Reference Citation Analysis]
200 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.3389/fphys.2011.00049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
201 Jung HK, Talley NJ. Role of the Duodenum in the Pathogenesis of Functional Dyspepsia: A Paradigm Shift. J Neurogastroenterol Motil. 2018;24:345-354. [PMID: 29791992 DOI: 10.5056/jnm18060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
202 Bercik P, Verdu EF, Collins SM. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am. 2005;34:235-245, vi-vii. [PMID: 15862932 DOI: 10.1016/j.gtc.2005.02.007] [Cited by in Crossref: 125] [Cited by in F6Publishing: 109] [Article Influence: 7.8] [Reference Citation Analysis]
203 Graziottin A. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval. Eur J Contracept Reprod Health Care 2016;21:93-105. [PMID: 26291185 DOI: 10.3109/13625187.2015.1077380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
204 Wood JD. Serotonergic Integration In the Intestinal Mucosa. CPD 2020;26:3010-4. [DOI: 10.2174/1381612826666200612161542] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
205 Basso L, Serhan N, Tauber M, Gaudenzio N. Peripheral neurons: Master regulators of skin and mucosal immune response. Eur J Immunol 2019;49:1984-97. [DOI: 10.1002/eji.201848027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
206 Li Y. Synaptic Plasticity and Synchrony in the Anterior Cingulate Cortex Circuitry: A Neural Network Approach to Causality of Chronic Visceral Pain and Associated Cognitive Deficits. Adv Neurobiol 2018;21:219-45. [PMID: 30334224 DOI: 10.1007/978-3-319-94593-4_8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
207 van den Wijngaard R, Welting O, de Jonge W, Boeckxstaens G. Parental Care, Mast Cells and Visceral Hypersensitivity. Journal of Pediatric Gastroenterology & Nutrition 2005;41:S12-3. [DOI: 10.1097/01.scs.0000180288.36118.1f] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
208 Aguilera-Lizarraga J, Florens MV, Viola MF, Jain P, Decraecker L, Appeltans I, Cuende-Estevez M, Fabre N, Van Beek K, Perna E, Balemans D, Stakenborg N, Theofanous S, Bosmans G, Mondelaers SU, Matteoli G, Ibiza Martínez S, Lopez-Lopez C, Jaramillo-Polanco J, Talavera K, Alpizar YA, Feyerabend TB, Rodewald HR, Farre R, Redegeld FA, Si J, Raes J, Breynaert C, Schrijvers R, Bosteels C, Lambrecht BN, Boyd SD, Hoh RA, Cabooter D, Nelis M, Augustijns P, Hendrix S, Strid J, Bisschops R, Reed DE, Vanner SJ, Denadai-Souza A, Wouters MM, Boeckxstaens GE. Local immune response to food antigens drives meal-induced abdominal pain. Nature 2021;590:151-6. [PMID: 33442055 DOI: 10.1038/s41586-020-03118-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 20.0] [Reference Citation Analysis]
209 Camilleri M, Carlson P, Valentin N, Acosta A, O'Neill J, Eckert D, Dyer R, Na J, Klee EW, Murray JA. Pilot study of small bowel mucosal gene expression in patients with irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2016;311:G365-G376. [PMID: 27445342 DOI: 10.1152/ajpgi.00037.2016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
210 Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203-209. [PMID: 17005763 DOI: 10.1136/gut.2006.100594] [Cited by in Crossref: 255] [Cited by in F6Publishing: 228] [Article Influence: 17.0] [Reference Citation Analysis]
211 Brierley SM, Hughes P, Harrington A, Ashley Blackshaw L. Innervation of the Gastrointestinal Tract by Spinal and Vagal Afferent Nerves. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 703-31. [DOI: 10.1016/b978-0-12-382026-6.00024-5] [Cited by in Crossref: 13] [Article Influence: 1.4] [Reference Citation Analysis]
212 Chi Y, Li C, Wu LH, Wang HH. The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome. Scand J Gastroenterol 2020;55:762-8. [PMID: 32493087 DOI: 10.1080/00365521.2020.1774925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
213 Singh V, Singh M, Schurman JV, Friesen CA. Histopathological changes in the gastroduodenal mucosa of children with functional dyspepsia. Pathology - Research and Practice 2018;214:1173-8. [DOI: 10.1016/j.prp.2018.06.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
214 Gobert AP, Sagrestani G, Delmas E, Wilson KT, Verriere TG, Dapoigny M, Del'homme C, Bernalier-Donadille A. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci Rep 2016;6:39399. [PMID: 27982124 DOI: 10.1038/srep39399] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
215 Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol 2007;13:3027-30. [PMID: 17589915 DOI: 10.3748/wjg.v13.i22.3027] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
216 Nogueira LT, Costa DV, Gomes AS, Martins CS, Silva AM, Coelho-Aguiar JM, Castelucci P, Lima-Júnior RC, Leitão RF, Moura-Neto V, Brito GA. The involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis. J Neuroinflammation 2017;14:79. [PMID: 28388962 DOI: 10.1186/s12974-017-0854-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
217 Magadmi R, Meszaros J, Damanhouri ZA, Seward EP. Secretion of Mast Cell Inflammatory Mediators Is Enhanced by CADM1-Dependent Adhesion to Sensory Neurons. Front Cell Neurosci 2019;13:262. [PMID: 31275114 DOI: 10.3389/fncel.2019.00262] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
218 Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Sim J, Jang KS. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea. Scand J Gastroenterol. 2014;49:43-51. [PMID: 24256141 DOI: 10.3109/00365521.2013.857712] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
219 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-230x-11-122] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
220 Stasi C, Rosselli M, Bellini M, Laffi G, Milani S. Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol. 2012;47:1177-1185. [PMID: 22766747 DOI: 10.1007/s00535-012-0627-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
221 Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-139. [PMID: 21602989 DOI: 10.5056/jnm.2011.17.2.131] [Cited by in Crossref: 155] [Cited by in F6Publishing: 114] [Article Influence: 15.5] [Reference Citation Analysis]
222 Ford AC, Talley NJ. Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review. J Gastroenterol. 2011;46:421-431. [PMID: 21331765 DOI: 10.1007/s00535-011-0379-9] [Cited by in Crossref: 121] [Cited by in F6Publishing: 103] [Article Influence: 12.1] [Reference Citation Analysis]
223 Pohl CS, Medland JE, Mackey E, Edwards LL, Bagley KD, DeWilde MP, Williams KJ, Moeser AJ. Early weaning stress induces chronic functional diarrhea, intestinal barrier defects, and increased mast cell activity in a porcine model of early life adversity. Neurogastroenterol Motil 2017;29. [PMID: 28573751 DOI: 10.1111/nmo.13118] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
224 De Filippis D, D'Amico A, Iuvone T. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. J Neuroendocrinol 2008;20 Suppl 1:20-5. [PMID: 18426495 DOI: 10.1111/j.1365-2826.2008.01674.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.6] [Reference Citation Analysis]
225 De Ponti F. Drug development for the irritable bowel syndrome: current challenges and future perspectives. Front Pharmacol. 2013;4:7. [PMID: 23378837 DOI: 10.3389/fphar.2013.00007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
226 Ang DC, Hilligoss J, Stump T. Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial. Clin J Pain 2015;31:836-42. [PMID: 25370135 DOI: 10.1097/AJP.0000000000000169] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
227 Wilcz-villega EM, Mcclean S, O’sullivan MA. Mast Cell Tryptase Reduces Junctional Adhesion Molecule-A (JAM-A) Expression in Intestinal Epithelial Cells: Implications for the Mechanisms of Barrier Dysfunction in Irritable Bowel Syndrome. American Journal of Gastroenterology 2013;108:1140-51. [DOI: 10.1038/ajg.2013.92] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 8.5] [Reference Citation Analysis]
228 Ohman L, Simrén M. New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2007;39:201-215. [PMID: 17267314 DOI: 10.1016/j.dld.2006.10.014] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
229 Sanger GJ. Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol 2004;141:1303-12. [PMID: 15023866 DOI: 10.1038/sj.bjp.0705742] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
230 Benini F, Mora A, Turini D, Bertolazzi S, Lanzarotto F, Ricci C, Villanacci V, Barbara G, Stanghellini V, Lanzini A. Slow gallbladder emptying reverts to normal but small intestinal transit of a physiological meal remains slow in celiac patients during gluten-free diet: Intestinal transit in celiacs. Neurogastroenterology & Motility 2012;24:100-e80. [DOI: 10.1111/j.1365-2982.2011.01822.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
231 Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, Isaacs NJ, Maldeniya L, Martin CM, Persson J. Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut. 2012;Jul 27; Epub ahead of print. [PMID: 22767422 DOI: 10.1136/gutjnl-2011-301856] [Cited by in Crossref: 127] [Cited by in F6Publishing: 118] [Article Influence: 14.1] [Reference Citation Analysis]
232 Corazziari ES. Pathophysiological approach to chronic diarrhoea. Intern Emerg Med 2012;7 Suppl 3:S251-4. [PMID: 23073865 DOI: 10.1007/s11739-012-0820-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
233 Ohashi K, Sato Y, Kawai M, Kurebayashi Y. Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats. Life Sci. 2008;82:419-423. [PMID: 18222490 DOI: 10.1016/j.lfs.2007.11.027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
234 Camilleri M, Andresen V. Current and novel therapeutic options for irritable bowel syndrome management. Dig Liver Dis. 2009;41:854-862. [PMID: 19665953 DOI: 10.1016/j.dld.2009.07.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
235 Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009;136:1979-1988. [PMID: 19457422 DOI: 10.1053/j.gastro.2009.02.074] [Cited by in Crossref: 456] [Cited by in F6Publishing: 396] [Article Influence: 38.0] [Reference Citation Analysis]
236 Ojetti V, Gigante G, Ainora M, Fiore F, Barbaro F, Gasbarrini A. Microflora imbalance and gastrointestinal diseases. Digestive and Liver Disease Supplements 2009;3:35-9. [DOI: 10.1016/s1594-5804(09)60017-6] [Cited by in Crossref: 10] [Article Influence: 0.8] [Reference Citation Analysis]
237 Feng B, La JH, Schwartz ES, Tanaka T, McMurray TP, Gebhart GF. Long-term sensitization of mechanosensitive and -insensitive afferents in mice with persistent colorectal hypersensitivity. Am J Physiol Gastrointest Liver Physiol 2012;302:G676-83. [PMID: 22268098 DOI: 10.1152/ajpgi.00490.2011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
238 Beatty JK, Bhargava A, Buret AG. Post-infectious irritable bowel syndrome: mechanistic insights into chronic disturbances following enteric infection. World J Gastroenterol. 2014;20:3976-3985. [PMID: 24744587 DOI: 10.3748/wjg.v20.i14.3976] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
239 Aich A, Afrin LB, Gupta K. Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci 2015;16:29069-92. [PMID: 26690128 DOI: 10.3390/ijms161226151] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 11.5] [Reference Citation Analysis]
240 Lettesjö H, Hansson T, Peterson C, Ung KA, Ringström G, Abrahamsson H, Simrén M. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol. 2006;41:54-59. [PMID: 16373277 DOI: 10.1080/00365520510023909] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
241 Lucarini E, Parisio C, Branca JJV, Segnani C, Ippolito C, Pellegrini C, Antonioli L, Fornai M, Micheli L, Pacini A, Bernardini N, Blandizzi C, Ghelardini C, Di Cesare Mannelli L. Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship. Cells 2020;9:E1772. [PMID: 32722246 DOI: 10.3390/cells9081772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
242 Winston JH, Sarna SK. Developmental origins of functional dyspepsia-like gastric hypersensitivity in rats. Gastroenterology. 2013;144:570-579.e3. [PMID: 23142231 DOI: 10.1053/j.gastro.2012.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
243 Lambertini C, Bombardi C, Zannoni A, Bernardini C, Dondi F, Morini M, Rinnovati R, Spadari A, Romagnoli N. Proteinase Activated Receptor 4 in the Jejunum of Healthy Horses and of Horses With Epiploic Hernia. Front Vet Sci 2020;7:158. [PMID: 32296721 DOI: 10.3389/fvets.2020.00158] [Reference Citation Analysis]
244 Barad AV, Saps M. Factors influencing functional abdominal pain in children. Curr Gastroenterol Rep 2008;10:294-301. [PMID: 18625141 DOI: 10.1007/s11894-008-0059-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
245 López-Pérez AE, Nurgali K, Abalo R. Painful neurotrophins and their role in visceral pain. Behav Pharmacol 2018;29:120-39. [PMID: 29543647 DOI: 10.1097/FBP.0000000000000386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
246 Brierley SM, Hughes PA, Page AJ, Kwan KY, Martin CM, O’Donnell TA, Cooper NJ, Harrington AM, Adam B, Liebregts T. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology. 2009;137:2084-2095.e3. [PMID: 19632231 DOI: 10.1053/j.gastro.2009.07.048] [Cited by in Crossref: 172] [Cited by in F6Publishing: 164] [Article Influence: 14.3] [Reference Citation Analysis]
247 Schaeffer DF, Kirsch R, Riddell RH. Mast cells and intestinal motility disorders (mastocytic enteritis/colitis). Dig Dis Sci 2012;57:1118-21. [PMID: 22466075 DOI: 10.1007/s10620-012-2123-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
248 Harris LA, Chang L. Irritable bowel syndrome: new and emerging therapies. Curr Opin Gastroenterol 2006;22:128-35. [PMID: 16462168 DOI: 10.1097/01.mog.0000208461.84513.f3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
249 Vazquez-Roque MI, Camilleri M, Smyrk T, Murray JA, O'Neill J, Carlson P, Lamsam J, Eckert D, Janzow D, Burton D, Ryks M, Rhoten D, Zinsmeister AR. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol. 2012;303:G1262-G1269. [PMID: 23042942 DOI: 10.1152/ajpgi.00294.2012] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
250 Schmulson M, Bielsa MV, Carmona-Sánchez R, Hernández A, López-Colombo A, López Vidal Y, Peláez-Luna M, Remes-Troche JM, Tamayo JL, Valdovinos MA. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome: an evidence-based review. Rev Gastroenterol Mex. 2014;79:96-134. [PMID: 24857420 DOI: 10.1016/j.rgmx.2014.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
251 Söderholm JD. Effects of Stress on Intestinal Mucosal Functions. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 1979-2000. [DOI: 10.1016/b978-0-12-382026-6.00074-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
252 Campaniello MA, Harrington AM, Martin CM, Ashley Blackshaw L, Brierley SM, Hughes PA. Activation of colo-rectal high-threshold afferent nerves by Interleukin-2 is tetrodotoxin-sensitive and upregulated in a mouse model of chronic visceral hypersensitivity. Neurogastroenterol Motil. 2016;28:54-63. [PMID: 26468044 DOI: 10.1111/nmo.12696] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
253 Cremon C, Pallotti F, Bacchilega M, Stanghellini V, Corinaldesi R, Barbara G. Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. Expert Rev Gastroenterol Hepatol. 2008;2:735-740. [PMID: 19090734 DOI: 10.1586/17474124.2.6.735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
254 Ferjan I, Lipnik-Štangelj M. Chronic pain treatment: the influence of tricyclic antidepressants on serotonin release and uptake in mast cells. Mediators Inflamm 2013;2013:340473. [PMID: 23710115 DOI: 10.1155/2013/340473] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
255 Lee H, Chung H, Park JC, Shin SK, lee SK, Lee YC. Heterogeneity of mucosal mast cell infiltration in subgroups of patients with esophageal chest pain. Neurogastroenterol Motil 2014;26:786-93. [DOI: 10.1111/nmo.12325] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
256 Collins SM. A role for the gut microbiota in IBS. Nat Rev Gastroenterol Hepatol. 2014;11:497-505. [PMID: 24751910 DOI: 10.1038/nrgastro.2014.40] [Cited by in Crossref: 183] [Cited by in F6Publishing: 161] [Article Influence: 26.1] [Reference Citation Analysis]
257 Ouyang A, Wrzos HF. Contribution of gender to pathophysiology and clinical presentation of IBS: should management be different in women? Am J Gastroenterol 2006;101:S602-9. [PMID: 17177863 DOI: 10.1111/j.1572-0241.2006.00975.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
258 Morales W, Pimentel M, Hwang L, Kunkel D, Pokkunuri V, Basseri B, Low K, Wang H, Conklin JL, Chang C. Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS. Dig Dis Sci 2011;56:2575-84. [DOI: 10.1007/s10620-011-1662-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
259 Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain. 2005;113:141-147. [PMID: 15621374 DOI: 10.1016/j.pain.2004.10.002] [Cited by in Crossref: 107] [Cited by in F6Publishing: 95] [Article Influence: 6.7] [Reference Citation Analysis]
260 Wood JD. Neuropathophysiology of the Irritable Bowel Syndrome. Physiology of the Gastrointestinal Tract. Elsevier; 2018. pp. 1643-68. [DOI: 10.1016/b978-0-12-809954-4.00067-0] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
261 Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol 2014;20:6031-43. [PMID: 24876726 DOI: 10.3748/wjg.v20.i20.6031] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
262 Melchior C, Aziz M, Aubry T, Gourcerol G, Quillard M, Zalar A, Coëffier M, Dechelotte P, Leroi AM, Ducrotté P. Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study. United European Gastroenterol J 2017;5:261-9. [PMID: 28344794 DOI: 10.1177/2050640616650062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
263 Drossman DA. What does the future hold for irritable bowel syndrome and the functional gastrointestinal disorders? J Clin Gastroenterol 2005;39:S251-6. [PMID: 15798493 DOI: 10.1097/01.mcg.0000156107.13247.69] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
264 Hughes PA, Zola H, Penttila IA, Blackshaw LA, Andrews JM, Krumbiegel D. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol. 2013;108:1066-1074. [PMID: 23649183 DOI: 10.1038/ajg.2013.120] [Cited by in Crossref: 97] [Cited by in F6Publishing: 79] [Article Influence: 12.1] [Reference Citation Analysis]
265 Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol. 2005;100:2560-2568. [PMID: 16279914 DOI: 10.1111/j.1572-0241.2005.00230.x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 161] [Article Influence: 11.3] [Reference Citation Analysis]
266 Staudacher HM, Whelan K. Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet. Proc Nutr Soc. 2016;75:306-318. [PMID: 26908093 DOI: 10.1017/s0029665116000021] [Cited by in Crossref: 52] [Cited by in F6Publishing: 22] [Article Influence: 10.4] [Reference Citation Analysis]
267 Spiller R. Impact of Diet on Symptoms of the Irritable Bowel Syndrome. Nutrients 2021;13:575. [PMID: 33572262 DOI: 10.3390/nu13020575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
268 Kubo M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T. Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults. Neurogastroenterol Motil. 2011;23:249-254. [PMID: 21122032 DOI: 10.1111/j.1365-2982.2010.01640.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
269 Lopes LV, Kussmann M. Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion. Expert Rev Proteomics. 2011;8:605-614. [PMID: 21999831 DOI: 10.1586/epr.11.50] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
270 Pigrau M, Rodiño-Janeiro BK, Casado-Bedmar M, Lobo B, Vicario M, Santos J, Alonso-Cotoner C. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome. Neurogastroenterol Motil 2016;28:463-86. [PMID: 26556786 DOI: 10.1111/nmo.12717] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
271 Chira A, Dumitrascu DL. Serum biomarkers for irritable bowel syndrome. Clujul Med 2015;88:258-64. [PMID: 26609254 DOI: 10.15386/cjmed-496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
272 Verdu EF. Editorial: Can gluten contribute to irritable bowel syndrome? Am J Gastroenterol. 2011;106:516-518. [PMID: 21378766 DOI: 10.1038/ajg.2010.490] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
273 Akhoundian M, Rüter A, Shinde S. Ultratrace Detection of Histamine Using a Molecularly-Imprinted Polymer-Based Voltammetric Sensor. Sensors (Basel) 2017;17:E645. [PMID: 28335573 DOI: 10.3390/s17030645] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
274 Friesen C, Colombo J, Schurman J. Update on the Role of Allergy in Pediatric Functional Abdominal Pain Disorders: A Clinical Perspective. Nutrients 2021;13:2056. [PMID: 34208479 DOI: 10.3390/nu13062056] [Reference Citation Analysis]
275 Fuentes IM, Christianson JA. The Influence of Early Life Experience on Visceral Pain. Front Syst Neurosci 2018;12:2. [PMID: 29434541 DOI: 10.3389/fnsys.2018.00002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
276 Spiller RC. Irritable bowel syndrome: gender, infection, lifestyle or what else? Dig Dis 2011;29:215-21. [PMID: 21734387 DOI: 10.1159/000323924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
277 Ek M, Roth B, Ekström P, Valentin L, Bengtsson M, Ohlsson B. Gastrointestinal symptoms among endometriosis patients--A case-cohort study. BMC Womens Health 2015;15:59. [PMID: 26272803 DOI: 10.1186/s12905-015-0213-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
278 Balemans D, Boeckxstaens GE, Talavera K, Wouters MM. Transient receptor potential ion channel function in sensory transduction and cellular signaling cascades underlying visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol. 2017;312:G635-G648. [PMID: 28385695 DOI: 10.1152/ajpgi.00401.2016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
279 Bonaz B, Sinniger V, Pellissier S. The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract. Front Immunol. 2017;8:1452. [PMID: 29163522 DOI: 10.3389/fimmu.2017.01452] [Cited by in Crossref: 95] [Cited by in F6Publishing: 81] [Article Influence: 23.8] [Reference Citation Analysis]
280 Azpiroz F, Bouin M, Camilleri M, Mayer EA, Poitras P, Serra J, Spiller RC. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil. 2007;19:62-88. [PMID: 17280586 DOI: 10.1111/j.1365-2982.2006.00875.x] [Cited by in Crossref: 244] [Cited by in F6Publishing: 230] [Article Influence: 17.4] [Reference Citation Analysis]
281 Conte C, Sichetti M, Traina G. Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells. Applied Sciences 2020;10:1828. [DOI: 10.3390/app10051828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
282 Kovacic K, Di Lorenzo C. Functional Nausea in Children. Journal of Pediatric Gastroenterology & Nutrition 2016;62:365-71. [DOI: 10.1097/mpg.0000000000001076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
283 Kim MY, Choi SW. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Nutr Res Pract 2021;15:411-30. [PMID: 34349876 DOI: 10.4162/nrp.2021.15.4.411] [Reference Citation Analysis]
284 Silos-Santiago I, Hannig G, Eutamene H, Ustinova EE, Bernier SG, Ge P, Graul C, Jacobson S, Jin H, Liong E. Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation. Pain. 2013;154:1820-1830. [PMID: 23748116 DOI: 10.1016/j.pain.2013.05.044] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
285 Agostini S, Eutamene H, Cartier C, Broccardo M, Improta G, Houdeau E, Petrella C, Ferrier L, Theodorou V, Bueno L. Evidence of central and peripheral sensitization in a rat model of narcotic bowel-like syndrome. Gastroenterology 2010;139:553-63, 563.e1-5. [PMID: 20347820 DOI: 10.1053/j.gastro.2010.03.046] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
286 Ceuleers H, Van Spaendonk H, Hanning N, Heirbaut J, Lambeir AM, Joossens J, Augustyns K, De Man JG, De Meester I, De Winter BY. Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases. World J Gastroenterol. 2016;22:10275-10286. [PMID: 28058009 DOI: 10.3748/wjg.v22.i47.10275] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
287 Ivashkin VT, Zolnikova OY. Irritable Bowel Syndrome in Terms of Changes in the Microbiota. Rossijskij žurnal gastroènterologii, gepatologii, koloproktologii 2019;29:84-92. [DOI: 10.22416/1382-4376-2019-29-1-84-92] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
288 de Graaf AA, Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 2008;53:73-168. [PMID: 17707144 DOI: 10.1016/S0065-2911(07)53002-X] [Cited by in Crossref: 32] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
289 Brierley SM, Linden DR. Neuroplasticity and dysfunction after gastrointestinal inflammation. Nat Rev Gastroenterol Hepatol 2014;11:611-27. [PMID: 25001973 DOI: 10.1038/nrgastro.2014.103] [Cited by in Crossref: 140] [Cited by in F6Publishing: 124] [Article Influence: 20.0] [Reference Citation Analysis]
290 Farrell KE, Keely S, Walker MM, Brichta AM, Graham BA, Callister RJ. Altered intrinsic and synaptic properties of lumbosacral dorsal horn neurons in a mouse model of colitis. Neuroscience 2017;362:152-67. [DOI: 10.1016/j.neuroscience.2017.08.029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
291 Sinagra E, Pompei G, Tomasello G, Cappello F, Morreale GC, Amvrosiadis G, Rossi F, Lo Monte AI, Rizzo AG, Raimondo D. Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol. 2016;22:2242-2255. [PMID: 26900287 DOI: 10.3748/wjg.v22.i7.2242] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 40] [Article Influence: 12.8] [Reference Citation Analysis]
292 Castillo-Courtade L, Han S, Lee S, Mian FM, Buck R, Forsythe P. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Allergy 2015;70:1091-102. [PMID: 25966668 DOI: 10.1111/all.12650] [Cited by in Crossref: 67] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
293 Broeders J, Duchateau S, Van Grinsven B, Vanaken W, Peeters M, Cleij T, Thoelen R, Wagner P, De Ceuninck W. Miniaturised eight-channel impedance spectroscopy unit as sensor platform for biosensor applications: Miniaturised eight-channel impedance spectroscopy unit for biosensor applications. Phys Status Solidi A 2011;208:1357-63. [DOI: 10.1002/pssa.201001199] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
294 Smolinska S, Jutel M, Crameri R, O'mahony L. Histamine and gut mucosal immune regulation. Allergy 2014;69:273-81. [DOI: 10.1111/all.12330] [Cited by in Crossref: 95] [Cited by in F6Publishing: 70] [Article Influence: 11.9] [Reference Citation Analysis]
295 Ohman L, Stridsberg M, Isaksson S, Jerlstad P, Simrén M. Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? Am J Gastroenterol. 2012;107:440-447. [PMID: 22233694 DOI: 10.1038/ajg.2011.458] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]
296 de Araujo AD, Mobli M, Castro J, Harrington AM, Vetter I, Dekan Z, Muttenthaler M, Wan J, Lewis RJ, King GF, Brierley SM, Alewood PF. Selenoether oxytocin analogues have analgesic properties in a mouse model of chronic abdominal pain. Nat Commun 2014;5. [DOI: 10.1038/ncomms4165] [Cited by in Crossref: 88] [Cited by in F6Publishing: 64] [Article Influence: 12.6] [Reference Citation Analysis]
297 Gecse K, Róka R, Séra T, Rosztóczy A, Annaházi A, Izbéki F, Nagy F, Molnár T, Szepes Z, Pávics L. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis. Digestion. 2012;85:40-46. [PMID: 22179430 DOI: 10.1159/000333083] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
298 Esquerre N, Basso L, Dubuquoy C, Djouina M, Chappard D, Blanpied C, Desreumaux P, Vergnolle N, Vignal C, Body-Malapel M. Aluminum Ingestion Promotes Colorectal Hypersensitivity in Rodents. Cell Mol Gastroenterol Hepatol 2019;7:185-96. [PMID: 30534582 DOI: 10.1016/j.jcmgh.2018.09.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
299 Bongaers E, Alenus J, Horemans F, Weustenraed A, Lutsen L, Vanderzande D, Cleij TJ, Troost FJ, Brummer R, Wagner P. A MIP-based biomimetic sensor for the impedimetric detection of histamine in different pH environments: A MIP-based biomimetic sensor for impedimetric detection of histamine. phys stat sol (a) 2010;207:837-43. [DOI: 10.1002/pssa.200983307] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
300 De Zuani M, Dal Secco C, Frossi B. Mast cells at the crossroads of microbiota and IBD. Eur J Immunol 2018;48:1929-37. [PMID: 30411335 DOI: 10.1002/eji.201847504] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
301 Andresen V, Camilleri M. Irritable bowel syndrome: recent and novel therapeutic approaches. Drugs. 2006;66:1073-1088. [PMID: 16789793 DOI: 10.2165/00003495-200666080-00004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
302 Chu H, Fox M, Zheng X, Deng Y, Long Y, Huang Z, Du L, Xu F, Dai N. Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome: Clinical Characteristics, Psychological Factors, and Peripheral Cytokines. Gastroenterol Res Pract. 2016;2016:3230859. [PMID: 27379166 DOI: 10.1155/2016/3230859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
303 DuPont HL. New insights and directions in travelers' diarrhea. Gastroenterol Clin North Am 2006;35:337-53, viii-ix. [PMID: 16880069 DOI: 10.1016/j.gtc.2006.03.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
304 Keles N, Yavuz Arican R, Coskun M, Elpek GO. Histamine induces the neuronal hypertrophy and increases the mast cell density in gastrointestinal tract. Exp Toxicol Pathol 2012;64:713-6. [PMID: 21316206 DOI: 10.1016/j.etp.2011.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
305 Videlock EJ, Chang L. Latest Insights on the Pathogenesis of Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:505-22. [PMID: 34304785 DOI: 10.1016/j.gtc.2021.04.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Balemans D, Mondelaers SU, Cibert-Goton V, Stakenborg N, Aguilera-Lizarraga J, Dooley J, Liston A, Bulmer DC, Vanden Berghe P, Boeckxstaens GE, Wouters MM. Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS. Sci Rep 2017;7:13606. [PMID: 29051514 DOI: 10.1038/s41598-017-12618-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
307 Fuentes IM, Walker NK, Pierce AN, Holt BR, Di Silvestro ER, Christianson JA. Neonatal maternal separation increases susceptibility to experimental colitis and acute stress exposure in male mice. IBRO Rep 2016;1:10-8. [PMID: 28164167 DOI: 10.1016/j.ibror.2016.07.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
308 Quigley EM, Flourie B. Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil. 2007;19:166-172. [PMID: 17300285 DOI: 10.1111/j.1365-2982.2006.00879.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 77] [Article Influence: 6.6] [Reference Citation Analysis]
309 Koyuncu Irmak D, Kilinc E, Tore F. Shared Fate of Meningeal Mast Cells and Sensory Neurons in Migraine. Front Cell Neurosci 2019;13:136. [PMID: 31024263 DOI: 10.3389/fncel.2019.00136] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
310 Quigley EM. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. Gastroenterol Clin North Am. 2011;40:207-222. [PMID: 21333908 DOI: 10.1016/j.gtc.2010.12.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
311 McClain JL, Mazzotta EA, Maradiaga N, Duque-Wilckens N, Grants I, Robison AJ, Christofi FL, Moeser AJ, Gulbransen BD. Histamine-dependent interactions between mast cells, glia, and neurons are altered following early-life adversity in mice and humans. Am J Physiol Gastrointest Liver Physiol 2020;319:G655-68. [PMID: 32996781 DOI: 10.1152/ajpgi.00041.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
312 Mearin F, Balboa A. [Post-infectious functional gastrointestinal disorders: from the acute episode to chronicity]. Gastroenterol Hepatol 2011;34:415-21. [PMID: 21641686 DOI: 10.1016/j.gastrohep.2011.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
313 Sundin J, Stridsberg M, Tap J, Derrien M, Le Nevé B, Doré J, Törnblom H, Simrén M, Öhman L. Fecal chromogranins and secretogranins are linked to the fecal and mucosal intestinal bacterial composition of IBS patients and healthy subjects. Sci Rep 2018;8:16821. [PMID: 30429499 DOI: 10.1038/s41598-018-35241-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
314 Felice VD, O'Mahony SM. The microbiome and disorders of the central nervous system. Pharmacol Biochem Behav 2017;160:1-13. [PMID: 28666895 DOI: 10.1016/j.pbb.2017.06.016] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
315 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.13.6041] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
316 Jiang W, Kirkup AJ, Grundy D. Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. J Physiol. 2011;589:3867-3882. [PMID: 21669977 DOI: 10.1113/jphysiol.2011.209478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
317 Carroccio A, Mansueto P, Morfino G, D'alcamo A, Di Paola V, Iacono G, Soresi M, Scerrino G, Maresi E, Gulotta G, Rini G, Bonventre S. Oligo-Antigenic Diet in the Treatment of Chronic Anal Fissures. Evidence for a Relationship Between Food Hypersensitivity and Anal Fissures. American Journal of Gastroenterology 2013;108:825-32. [DOI: 10.1038/ajg.2013.58] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
318 Carotti S, Guarino MP, Cicala M, Perrone G, Alloni R, Segreto F, Rabitti C, Morini S. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients. Neurogastroenterol Motil. 2010;22:866-73, e232. [PMID: 20426797 DOI: 10.1111/j.1365-2982.2010.01510.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
319 Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, De Giorgio R, Bartesaghi G, Canovi B, Barbara G. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther. 2009;30:245-252. [PMID: 19438846 DOI: 10.1111/j.1365-2036.2009.04041.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 7.4] [Reference Citation Analysis]
320 Bharucha AE, Brookes SJ. Neurophysiologic Mechanisms of Human Large Intestinal Motility. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 977-1022. [DOI: 10.1016/b978-0-12-382026-6.00036-1] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
321 Clarke G, Fitzgerald P, Hennessy AA, Cassidy EM, Quigley EM, Ross P, Stanton C, Cryan JF, Dinan TG. Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome. J Lipid Res. 2010;51:1186-1192. [PMID: 19965606 DOI: 10.1194/jlr.p000695] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
322 Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7:163-173. [PMID: 20101257 DOI: 10.1038/nrgastro.2010.4] [Cited by in Crossref: 362] [Cited by in F6Publishing: 319] [Article Influence: 32.9] [Reference Citation Analysis]
323 Magen E, Chikovani T. Possible therapeutic role of IgE blockade in irritable bowel syndrome. World J Gastroenterol 2016;22:9451-6. [PMID: 27920467 DOI: 10.3748/wjg.v22.i43.9451] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
324 Truong TT, Naliboff BD, Chang L. Novel techniques to study visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2008;10:369-378. [PMID: 18627648 DOI: 10.1007/s11894-008-0071-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
325 Quigley EM. The Use of Probiotics in Functional Bowel Disease. Gastroenterology Clinics of North America 2005;34:533-45. [DOI: 10.1016/j.gtc.2005.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
326 Fuentes IM, Christianson JA. Ion channels, ion channel receptors, and visceral hypersensitivity in irritable bowel syndrome. Neurogastroenterol Motil 2016;28:1613-8. [PMID: 27781369 DOI: 10.1111/nmo.12979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
327 Spiller RC. Potential future therapies for Irritable Bowel Syndrome: Will Disease Modifying Therapy as Opposed to Symptomatic Control Become a Reality? Gastroenterology Clinics of North America 2005;34:337-54. [DOI: 10.1016/j.gtc.2005.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
328 Shakola F, Suri P, Ruggiu M. Splicing Regulation of Pro-Inflammatory Cytokines and Chemokines: At the Interface of the Neuroendocrine and Immune Systems. Biomolecules 2015;5:2073-100. [PMID: 26371053 DOI: 10.3390/biom5032073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
329 Lee YY, Annamalai C, Rao SSC. Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0595-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
330 Mosińska P, Storr M, Fichna J. The role of AST-120 and protein-bound uremic toxins in irritable bowel syndrome: a therapeutic perspective. Therap Adv Gastroenterol 2015;8:278-84. [PMID: 26327918 DOI: 10.1177/1756283X15587866] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
331 Van Op den bosch J, Van Nassauw L, Van Marck E, Timmermans JP. Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells. Am J Physiol Gastrointest Liver Physiol 2009;297:G406-17. [PMID: 19477916 DOI: 10.1152/ajpgi.00059.2009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
332 Mueller K, Michel K, Krueger D, Demir IE, Ceyhan GO, Zeller F, Kreis ME, Schemann M. Activity of Protease-Activated Receptors in the Human Submucous Plexus. Gastroenterology 2011;141:2088-2097.e1. [DOI: 10.1053/j.gastro.2011.08.034] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
333 Kindt S, Tertychnyy A, de Hertogh G, Geboes K, Tack J. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil. 2009;21:832-e56. [PMID: 19460107 DOI: 10.1111/j.1365-2982.2009.01299.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 6.3] [Reference Citation Analysis]
334 Dothel G, Barbaro MR, Boudin H, Vasina V, Cremon C, Gargano L, Bellacosa L, De Giorgio R, Le Berre-Scoul C, Aubert P, Neunlist M, De Ponti F, Stanghellini V, Barbara G. Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology. 2015;148:1002-1011.e4. [PMID: 25655556 DOI: 10.1053/j.gastro.2015.01.042] [Cited by in Crossref: 85] [Cited by in F6Publishing: 73] [Article Influence: 14.2] [Reference Citation Analysis]
335 Jin X, Gharibani P, Yin J, Chen JDZ. Neuro-Immune Modulation Effects of Sacral Nerve Stimulation for Visceral Hypersensitivity in Rats. Front Neurosci 2021;15:645393. [PMID: 34276280 DOI: 10.3389/fnins.2021.645393] [Reference Citation Analysis]
336 Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on Irritable Bowel Syndrome. J Clin Gastroenterol. 2012;46:356-366. [PMID: 22499071 DOI: 10.1097/mcg.0b013e318247157c] [Cited by in Crossref: 95] [Cited by in F6Publishing: 35] [Article Influence: 10.6] [Reference Citation Analysis]
337 D'Andrea MR, Saban MR, Gerard NP, Wershil BK, Saban R. Lack of neurokinin-1 receptor expression affects tissue mast cell numbers but not their spatial relationship with nerves. Am J Physiol Regul Integr Comp Physiol 2005;288:R491-500. [PMID: 15458971 DOI: 10.1152/ajpregu.00452.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
338 Vermeulen W, De Man JG, Pelckmans PA, De Winter BY. Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol. 2014;20:1005-1020. [PMID: 24574773 DOI: 10.3748/wjg.v20.i4.1005] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 47] [Article Influence: 8.7] [Reference Citation Analysis]
339 Kajander K, Hatakka K, Poussa T, Färkkilä M, Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther. 2005;22:387-394. [PMID: 16128676 DOI: 10.1111/j.1365-2036.2005.02579.x] [Cited by in Crossref: 239] [Cited by in F6Publishing: 199] [Article Influence: 14.9] [Reference Citation Analysis]
340 Theodorou V, Ait Belgnaoui A, Agostini S, Eutamene H. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome. Gut Microbes. 2014;5:430-436. [PMID: 25184834 DOI: 10.4161/gmic.29796] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 7.8] [Reference Citation Analysis]
341 Quigley EM. Changing face of irritable bowel syndrome. World J Gastroenterol 2006;12:1-5. [PMID: 16440408 DOI: 10.3748/wjg.v12.i1.1] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
342 Moeser AJ, Ryan KA, Nighot PK, Blikslager AT. Gastrointestinal dysfunction induced by early weaning is attenuated by delayed weaning and mast cell blockade in pigs. Am J Physiol Gastrointest Liver Physiol 2007;293:G413-21. [PMID: 17525151 DOI: 10.1152/ajpgi.00304.2006] [Cited by in Crossref: 127] [Cited by in F6Publishing: 109] [Article Influence: 9.1] [Reference Citation Analysis]
343 Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets 2020;24:511-23. [PMID: 32249629 DOI: 10.1080/14728222.2020.1752181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
344 Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators. J Dig Dis 2016;17:572-81. [PMID: 27426409 DOI: 10.1111/1751-2980.12379] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
345 Bergonzelli GE, Blum S, Brussow H, Corthésy-Theulaz I. Probiotics as a treatment strategy for gastrointestinal diseases? Digestion. 2005;72:57-68. [PMID: 16113543 DOI: 10.1159/000087638] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
346 López-gómez L, Bagüés A, Uranga JA, Abalo R. Preclinical models of irritable bowel syndrome. A Comprehensive Overview of Irritable Bowel Syndrome. Elsevier; 2020. pp. 233-76. [DOI: 10.1016/b978-0-12-821324-7.00012-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Lashermes A, Boudieu L, Barbier J, Sion B, Gelot A, Barnich N, Ardid D, Carvalho FA. Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period. Gut Microbes 2018;9:26-37. [PMID: 28806140 DOI: 10.1080/19490976.2017.1361091] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
348 Barbara G, Scaioli E, Barbaro MR, Biagi E, Laghi L, Cremon C, Marasco G, Colecchia A, Picone G, Salfi N. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut. 2017;66:1252-1261. [PMID: 27618836 DOI: 10.1136/gutjnl-2016-312377] [Cited by in Crossref: 83] [Cited by in F6Publishing: 62] [Article Influence: 16.6] [Reference Citation Analysis]
349 Chang L. Neuroendocrine and neuroimmune markers in IBS: pathophysiological role or epiphenomenon. Gastroenterology. 2006;130:596-600. [PMID: 16472611 DOI: 10.1053/j.gastro.2005.12.047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
350 Gloro R, Ducrotte P, Reimund JM. Protease-activated receptors: potential therapeutic targets in irritable bowel syndrome? Expert Opin Ther Targets 2005;9:1079-95. [PMID: 16185159 DOI: 10.1517/14728222.9.5.1079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
351 Wood JD. Enteric nervous system: sensory physiology, diarrhea and constipation. Curr Opin Gastroenterol 2010;26:102-8. [PMID: 19926984 DOI: 10.1097/MOG.0b013e328334df4f] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
352 Camilleri M, Carlson P, McKinzie S, Zucchelli M, D’Amato M, Busciglio I, Burton D, Zinsmeister AR. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil. 2011;23:935-e398. [PMID: 21752155 DOI: 10.1111/j.1365-2982.2011.01749.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
353 Aerssens J, Hillsley K, Peeters PJ, de Hoogt R, Stanisz A, Lin JH, Van den Wyngaert I, Göhlmann HW, Grundy D, Stead RH, Coulie B. Alterations in the brain-gut axis underlying visceral chemosensitivity in Nippostrongylus brasiliensis-infected mice. Gastroenterology 2007;132:1375-87. [PMID: 17408648 DOI: 10.1053/j.gastro.2007.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
354 Furuno T, Ito A, Koma Y, Watabe K, Yokozaki H, Bienenstock J, Nakanishi M, Kitamura Y. The Spermatogenic Ig Superfamily/Synaptic Cell Adhesion Molecule Mast-Cell Adhesion Molecule Promotes Interaction with Nerves. J Immunol 2005;174:6934-42. [DOI: 10.4049/jimmunol.174.11.6934] [Cited by in Crossref: 83] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
355 Spiller RC. Irritable bowel syndrome. Br Med Bull. 2004;72:15-29. [PMID: 15767561 DOI: 10.1093/bmb/ldh039] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
356 Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK, Cho SW. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. Journal of Gastroenterology and Hepatology 2008;23:1689-94. [DOI: 10.1111/j.1440-1746.2008.05574.x] [Cited by in Crossref: 112] [Cited by in F6Publishing: 109] [Article Influence: 8.6] [Reference Citation Analysis]
357 Malone MA. Irritable bowel syndrome. Prim Care 2011;38:433-47; viii. [PMID: 21872090 DOI: 10.1016/j.pop.2011.05.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
358 Burns G, Carroll G, Mathe A, Horvat J, Foster P, Walker MM, Talley NJ, Keely S. Evidence for Local and Systemic Immune Activation in Functional Dyspepsia and the Irritable Bowel Syndrome: A Systematic Review. Am J Gastroenterol. 2019;114:429-436. [PMID: 30839392 DOI: 10.1038/s41395-018-0377-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 21.5] [Reference Citation Analysis]
359 Ahmad OF, Akbar A. Microbiome, antibiotics and irritable bowel syndrome. Br Med Bull 2016;120:91-9. [DOI: 10.1093/bmb/ldw038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
360 Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol. 2013;19:9256-9270. [PMID: 24409053 DOI: 10.3748/wjg.v19.i48.9256] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
361 Rey de Castro NG, Miller V, Carruthers HR, Whorwell PJ. Irritable bowel syndrome: a comparison of subtypes. J Gastroenterol Hepatol. 2015;30:279-285. [PMID: 25091059 DOI: 10.1111/jgh.12704] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
362 Hilmi I, Hartono JL, Pailoor J, Mahadeva S, Goh KL. Low prevalence of 'classical' microscopic colitis but evidence of microscopic inflammation in Asian irritable bowel syndrome patients with diarrhoea. BMC Gastroenterol 2013;13:80. [PMID: 23651739 DOI: 10.1186/1471-230X-13-80] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
363 Sarnelli G, Pesce M, Seguella L, Lu J, Efficie E, Tack J, Elisa De Palma FD, D'Alessandro A, Esposito G. Impaired Duodenal Palmitoylethanolamide Release Underlies Acid-Induced Mast Cell Activation in Functional Dyspepsia. Cell Mol Gastroenterol Hepatol 2021;11:841-55. [PMID: 33065341 DOI: 10.1016/j.jcmgh.2020.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Sofia MA, Ciorba MA, Meckel K, Lim CK, Guillemin GJ, Weber CR, Bissonnette M, Pekow JR. Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis. Inflamm Bowel Dis 2018;24:1471-80. [PMID: 29796641 DOI: 10.1093/ibd/izy103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 19.5] [Reference Citation Analysis]
365 Rajilić–stojanović M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, de Vos WM. Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome. Gastroenterology 2011;141:1792-801. [DOI: 10.1053/j.gastro.2011.07.043] [Cited by in Crossref: 582] [Cited by in F6Publishing: 504] [Article Influence: 58.2] [Reference Citation Analysis]
366 Demir IE, Friess H, Ceyhan GO. Neural plasticity in pancreatitis and pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2015;12:649-659. [PMID: 26460352 DOI: 10.1038/nrgastro.2015.166] [Cited by in Crossref: 87] [Cited by in F6Publishing: 76] [Article Influence: 14.5] [Reference Citation Analysis]
367 Zhao JM, Li L, Chen L, Shi Y, Li YW, Shang HX, Wu LY, Weng ZJ, Bao CH, Wu HG. Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome. World J Gastroenterol 2017;23:2928-39. [PMID: 28522910 DOI: 10.3748/wjg.v23.i16.2928] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
368 Carroccio A, Brusca I, Mansueto P, Soresi M, D’Alcamo A, Ambrosiano G, Pepe I, Iacono G, Lospalluti ML, La Chiusa SM. Fecal assays detect hypersensitivity to cow’s milk protein and gluten in adults with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2011;9:965-971.e3. [PMID: 21839707 DOI: 10.1016/j.cgh.2011.07.030] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
369 Grenham S, Clarke G, Cryan JF, Dinan TG. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:94. [PMID: 22162969 DOI: 10.3389/fphys.2011.00094] [Cited by in Crossref: 425] [Cited by in F6Publishing: 363] [Article Influence: 42.5] [Reference Citation Analysis]
370 Rau B, Friesen CA, Daniel JF, Qadeer A, You-li D, Roberts CC, Holcomb GW. Gallbladder wall inflammatory cells in pediatric patients with biliary dyskinesia and cholelithiasis: a pilot study. Journal of Pediatric Surgery 2006;41:1545-8. [DOI: 10.1016/j.jpedsurg.2006.05.015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
371 Mischel RA, Dewey WL, Akbarali HI. Tolerance to Morphine-Induced Inhibition of TTX-R Sodium Channels in Dorsal Root Ganglia Neurons Is Modulated by Gut-Derived Mediators. iScience 2018;2:193-209. [PMID: 29888757 DOI: 10.1016/j.isci.2018.03.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
372 Hoogerwerf WA, Gondesen K, Xiao SY, Winston JH, Willis WD, Pasricha PJ. The role of mast cells in the pathogenesis of pain in chronic pancreatitis. BMC Gastroenterol. 2005;5:8. [PMID: 15745445 DOI: 10.1186/1471-230x-5-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
373 Kanazawa M, Fukudo S. Relationship between infectious gastroenteritis and irritable bowel syndrome. Clin J Gastroenterol. 2014;7:14-18. [PMID: 26183503 DOI: 10.1007/s12328-013-0444-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
374 Spaziani R, Bayati A, Redmond K, Bajaj H, Mazzadi S, Bienenstock J, Collins SM, Kamath MV. Vagal dysfunction in irritable bowel syndrome assessed by rectal distension and baroreceptor sensitivity. Neurogastroenterol Motil. 2008;20:336-342. [PMID: 18179607 DOI: 10.1111/j.1365-2982.2007.01042.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
375 Grundy D, Schemann M. Enteric nervous system. Curr Opin Gastroenterol. 2006;22:102-110. [PMID: 16462164 DOI: 10.1097/01.mog.0000208459.46395.16] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
376 Fuentes IM, Pierce AN, Di Silvestro ER, Maloney MO, Christianson JA. Differential Influence of Early Life and Adult Stress on Urogenital Sensitivity and Function in Male Mice. Front Syst Neurosci 2017;11:97. [PMID: 29379420 DOI: 10.3389/fnsys.2017.00097] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
377 Sand E, Themner-Persson A, Ekblad E. Corticotropin releasing factor-distribution in rat intestine and role in neuroprotection. Regul Pept 2011;166:68-75. [PMID: 20801165 DOI: 10.1016/j.regpep.2010.08.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
378 Ahn JY, Lee KH, Choi CH, Kim JW, Lee HW, Kim JW, Kim MK, Kwon GY, Han S, Kim SE. Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci. 2014;59:1001-1011. [PMID: 24282051 DOI: 10.1007/s10620-013-2930-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
379 Kamphuis JBJ, Guiard B, Leveque M, Olier M, Jouanin I, Yvon S, Tondereau V, Rivière P, Guéraud F, Chevolleau S, Noguer-Meireles MH, Martin JF, Debrauwer L, Eutamène H, Theodorou V. Lactose and Fructo-oligosaccharides Increase Visceral Sensitivity in Mice via Glycation Processes, Increasing Mast Cell Density in Colonic Mucosa. Gastroenterology 2020;158:652-663.e6. [PMID: 31711923 DOI: 10.1053/j.gastro.2019.10.037] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
380 Foley S, Garsed K, Singh G, Duroudier NP, Swan C, Hall IP, Zaitoun A, Bennett A, Marsden C, Holmes G, Walls A, Spiller RC. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation. Gastroenterology. 2011;140:1434-43.e1. [PMID: 21315720 DOI: 10.1053/j.gastro.2011.01.052] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 7.7] [Reference Citation Analysis]
381 Sirianni J, Ibrahim M, Patwardhan A. Chronic Pain Syndromes, Mechanisms, and Current Treatments. Molecular and Cell Biology of Pain. Elsevier; 2015. pp. 565-611. [DOI: 10.1016/bs.pmbts.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
382 Henderson WA, Shankar R, Taylor TJ, Del Valle-Pinero AY, Kleiner DE, Kim KH, Youssef NN. Inverse relationship of interleukin-6 and mast cells in children with inflammatory and non-inflammatory abdominal pain phenotypes. World J Gastrointest Pathophysiol 2012;3:102-8. [PMID: 23516176 DOI: 10.4291/wjgp.v3.i6.102] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
383 Kleij HP, Bienenstock J. Significance of Conversation between Mast Cells and Nerves. Allergy Asthma Clin Immunol 2005;1:65-80. [PMID: 20529227 DOI: 10.1186/1710-1492-1-2-65] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
384 Ostertag D, Buhner S, Michel K, Pehl C, Kurjak M, Götzberger M, Schulte-Frohlinde E, Frieling T, Enck P, Phillip J, Schemann M. Reduced Responses of Submucous Neurons from Irritable Bowel Syndrome Patients to a Cocktail Containing Histamine, Serotonin, TNFα, and Tryptase (IBS-Cocktail). Front Neurosci 2015;9:465. [PMID: 26733780 DOI: 10.3389/fnins.2015.00465] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
385 Bustos Fernandez LM, Lasa JS, Man F. Intestinal microbiota: its role in digestive diseases. J Clin Gastroenterol. 2014;48:657-666. [PMID: 24921207 DOI: 10.1097/mcg.0000000000000153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
386 Shahbazkhani B, Sadeghi A, Malekzadeh R, Khatavi F, Etemadi M, Kalantri E, Rostami-Nejad M, Rostami K. Non-Celiac Gluten Sensitivity Has Narrowed the Spectrum of Irritable Bowel Syndrome: A Double-Blind Randomized Placebo-Controlled Trial. Nutrients 2015;7:4542-54. [PMID: 26056920 DOI: 10.3390/nu7064542] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
387 Fioramonti J, Gebhart GF. In vivo and transgenic animal models used to study visceral hypersensitivity. Neurogastroenterol Motil. 2007;19:20-28. [PMID: 17280583 DOI: 10.1111/j.1365-2982.2006.00872.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
388 Spiller RC. Is IBS caused by infectious diarrhea? Nat Clin Pract Gastroenterol Hepatol 2007;4:642-3. [PMID: 17984983 DOI: 10.1038/ncpgasthep0983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
389 Hahn HP, Hornick JL. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol 2007;31:1669-76. [PMID: 18059223 DOI: 10.1097/PAS.0b013e318078ce7a] [Cited by in Crossref: 54] [Cited by in F6Publishing: 12] [Article Influence: 3.9] [Reference Citation Analysis]
390 Halliez MC, Buret AG. Gastrointestinal Parasites and the Neural Control of Gut Functions. Front Cell Neurosci 2015;9:452. [PMID: 26635531 DOI: 10.3389/fncel.2015.00452] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
391 Rho SG, Kim YS, Choi SC, Lee MY. Sweet food improves chronic stress-induced irritable bowel syndrome-like symptoms in rats. World J Gastroenterol 2014;20:2365-73. [PMID: 24605034 DOI: 10.3748/wjg.v20.i9.2365] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
392 Kovacic K. Current concepts in functional gastrointestinal disorders. Current Opinion in Pediatrics 2015;27:619-24. [DOI: 10.1097/mop.0000000000000262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
393 Greenwood-van Meerveld B, Moloney RD, Johnson AC, Vicario M. Mechanisms of Stress-Induced Visceral Pain: Implications in Irritable Bowel Syndrome. J Neuroendocrinol 2016;28. [DOI: 10.1111/jne.12361] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
394 Clark C, DeLegge M. Irritable bowel syndrome: a practical approach. Nutr Clin Pract 2008;23:263-7. [PMID: 18595858 DOI: 10.1177/0884533608318107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
395 Long MD, Drossman DA. Inflammatory bowel disease, irritable bowel syndrome, or what?: A challenge to the functional-organic dichotomy. Am J Gastroenterol. 2010;105:1796-1798. [PMID: 20686466 DOI: 10.1038/ajg.2010.162] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
396 Giancola F, Volta U, Repossi R, Latorre R, Beeckmans D, Carbone F, Van den Houte K, Bianco F, Bonora E, Gori A, Costanzini A, Boschetti E, Caio G, Vanuytsel T, Stanghellini V, Tack J, De Giorgio R. Mast cell-nerve interactions correlate with bloating and abdominal pain severity in patients with non-celiac gluten / wheat sensitivity. Neurogastroenterol Motil 2020;32:e13814. [PMID: 32022388 DOI: 10.1111/nmo.13814] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
397 Ostertag D, Annahazi A, Krueger D, Michel K, Demir IE, Ceyhan GO, Zeller F, Schemann M. Tryptase potentiates enteric nerve activation by histamine and serotonin: Relevance for the effects of mucosal biopsy supernatants from irritable bowel syndrome patients. Neurogastroenterol Motil 2017;29. [PMID: 28374503 DOI: 10.1111/nmo.13070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
398 von Rahden BHA, Jurowich C, Kircher S, Lazariotou M, Jung M, Germer C, Grimm M. Allergic Predisposition, Histamine and Histamine Receptor Expression (H1R, H2R) Are Associated with Complicated Courses of Sigmoid Diverticulitis. J Gastrointest Surg 2012;16:173-82. [DOI: 10.1007/s11605-011-1702-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
399 Kraneveld AD, Sagar S, Garssen J, Folkerts G. The two faces of mast cells in food allergy and allergic asthma: the possible concept of Yin Yang. Biochim Biophys Acta 2012;1822:93-9. [PMID: 21757003 DOI: 10.1016/j.bbadis.2011.06.013] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
400 Barbaro MR, Fuschi D, Cremon C, Carapelle M, Dino P, Marcellini MM, Dothel G, De Ponti F, Stanghellini V, Barbara G. Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators. Neurogastroenterol Motil 2018;30:e13388. [DOI: 10.1111/nmo.13388] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
401 Zanini B, Lanzarotto F, Villanacci V, Carabellese N, Ricci C, Lanzini A. Clinical expression of lymphocytic duodenosis in “mild enteropathy” celiac disease and in functional gastrointestinal syndromes. Scandinavian Journal of Gastroenterology 2014;49:794-800. [DOI: 10.3109/00365521.2014.919017] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
402 Carco C, Young W, Gearry RB, Talley NJ, McNabb WC, Roy NC. Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Front Cell Infect Microbiol 2020;10:468. [PMID: 33014892 DOI: 10.3389/fcimb.2020.00468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
403 Stanghellini V, Barbara G, Cogliandro R, Salvioli B, Cremon C, De Giorgio R, Corinaldesi R. Overlap Between GERD and IBS: Irrefutable But Subtle. Journal of Clinical Gastroenterology 2007;41:S114-7. [DOI: 10.1097/mcg.0b013e31803d0f94] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
404 Lee KN, Lee OY. The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract. 2016;2016:2031480. [PMID: 28115927 DOI: 10.1155/2016/2031480] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
405 Krämer S, Sellge G, Lorentz A, Krueger D, Schemann M, Feilhauer K, Gunzer F, Bischoff SC. Selective activation of human intestinal mast cells by Escherichia coli hemolysin. J Immunol 2008;181:1438-45. [PMID: 18606698 DOI: 10.4049/jimmunol.181.2.1438] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
406 Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol. 2014;20:8886-8897. [PMID: 25083061 DOI: 10.3748/wjg.v20.i27.8886] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
407 Friesen CA, Neilan N, Daniel JF, Radford K, Schurman JV, Li DY, Andre L, St Peter SD, Holcomb GW 3rd. Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia. BMC Res Notes 2011;4:322. [PMID: 21896203 DOI: 10.1186/1756-0500-4-322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
408 Eller-Smith OC, Nicol AL, Christianson JA. Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions. Front Cell Neurosci 2018;12:35. [PMID: 29487504 DOI: 10.3389/fncel.2018.00035] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 19.3] [Reference Citation Analysis]
409 Barbara G, Stanghellini V, Cremon C, De Giorgio R, Gargano L, Cogliandro R, Pallotti F, Corinaldesi R. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. J Clin Gastroenterol 2008;42 Suppl 3 Pt 2:S214-7. [PMID: 18685517 DOI: 10.1097/MCG.0b013e31817da129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
410 Gupta K, Harvima IT. Mast cell-neural interactions contribute to pain and itch. Immunol Rev 2018;282:168-87. [PMID: 29431216 DOI: 10.1111/imr.12622] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 43.0] [Reference Citation Analysis]
411 Sun H, Ma Y, An S, Wang Z. Altered gene expression signatures by calcitonin gene-related peptide promoted mast cell activity in the colon of stress-induced visceral hyperalgesia mice. Neurogastroenterol Motil 2021;33:e14073. [PMID: 33382180 DOI: 10.1111/nmo.14073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
412 Kindt S, Van Oudenhove L, Broekaert D, Kasran A, Ceuppens JL, Bossuyt X, Fischler B, Tack J. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:389-398. [PMID: 19126184 DOI: 10.1111/j.1365-2982.2008.01220.x] [Cited by in Crossref: 92] [Cited by in F6Publishing: 84] [Article Influence: 7.1] [Reference Citation Analysis]
413 Martínez C, González-Castro A, Vicario M, Santos J. Cellular and molecular basis of intestinal barrier dysfunction in the irritable bowel syndrome. Gut Liver. 2012;6:305-315. [PMID: 22844557 DOI: 10.5009/gnl.2012.6.3.305] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
414 Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377-1390. [PMID: 16678553 DOI: 10.1053/j.gastro.2006.03.008] [Cited by in Crossref: 1337] [Cited by in F6Publishing: 1009] [Article Influence: 89.1] [Reference Citation Analysis]
415 O'Mahony SM, Felice VD, Nally K, Savignac HM, Claesson MJ, Scully P, Woznicki J, Hyland NP, Shanahan F, Quigley EM, Marchesi JR, O'Toole PW, Dinan TG, Cryan JF. Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats. Neuroscience 2014;277:885-901. [PMID: 25088912 DOI: 10.1016/j.neuroscience.2014.07.054] [Cited by in Crossref: 160] [Cited by in F6Publishing: 135] [Article Influence: 22.9] [Reference Citation Analysis]
416 sharkey KA. Visceral sensation and colitis: inflammation and hypersensitivity do not always go hand in hand. Neurogastroenterol Motil 2006;18:87-90. [DOI: 10.1111/j.1365-2982.2005.00743.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
417 Willot S, Gauthier C, Patey N, Faure C. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:734-739, e347. [PMID: 22625872 DOI: 10.1111/j.1365-2982.2012.01933.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
418 Dupont AW. Post-infectious irritable bowel syndrome. Curr Gastroenterol Rep. 2007;9:378-384. [PMID: 17991338 DOI: 10.1007/s11894-007-0046-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
419 Kodani M, Fukui H, Tomita T, Oshima T, Watari J, Miwa H. Association between gastrointestinal motility and macrophage/mast cell distribution in mice during the healing stage after DSS‑induced colitis. Mol Med Rep 2018;17:8167-72. [PMID: 29693127 DOI: 10.3892/mmr.2018.8926] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
420 Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009;136:2003-2014. [PMID: 19457424 DOI: 10.1053/j.gastro.2009.01.075] [Cited by in Crossref: 333] [Cited by in F6Publishing: 288] [Article Influence: 27.8] [Reference Citation Analysis]
421 Spak E, Casselbrant A, Olbers T, Lönroth H, Fändriks L. Angiotensin II-induced contractions in human jejunal wall musculature in vitro. Acta Physiol (Oxf) 2008;193:181-90. [PMID: 18081740 DOI: 10.1111/j.1748-1716.2007.01826.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
422 Wood JD. Histamine, mast cells, and the enteric nervous system in the irritable bowel syndrome, enteritis, and food allergies. Gut. 2006;55:445-447. [PMID: 16531524 DOI: 10.1136/gut.2005.079046] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
423 Bengmark S, Martindale R. Prebiotics and synbiotics in clinical medicine. Nutr Clin Pract. 2005;20:244-261. [PMID: 16207660 DOI: 10.1177/0115426505020002244] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
424 Zhang R, Zou N, Li J, Lv H, Wei J, Fang XC, Qian JM. Elevated expression of c-fos in central nervous system correlates with visceral hypersensitivity in irritable bowel syndrome (IBS): a new target for IBS treatment. Int J Colorectal Dis 2011;26:1035-44. [PMID: 21340718 DOI: 10.1007/s00384-011-1153-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
425 Nelson TA, Holmes S, Alekseyenko AV, Shenoy M, Desantis T, Wu CH, Andersen GL, Winston J, Sonnenburg J, Pasricha PJ, Spormann A. PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity. Neurogastroenterol Motil 2011;23:169-77, e41-2. [PMID: 21129126 DOI: 10.1111/j.1365-2982.2010.01637.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
426 Törnblom H, Abrahamsson H, Barbara G, Hellström PM, Lindberg G, Nyhlin H, Ohlsson B, Simrèn M, Sjölund K, Sjövall H, Schmidt PT, Öhman L, Group TSM. Inflammation as a cause of functional bowel disorders. Scandinavian Journal of Gastroenterology 2005;40:1140-8. [DOI: 10.1080/00365520510023657] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
427 Oksaharju A, Kankainen M, Kekkonen RA, Lindstedt KA, Kovanen PT, Korpela R, Miettinen M. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J Gastroenterol. 2011;17:750-759. [PMID: 21390145 DOI: 10.3748/wjg.v17.i6.750] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
428 Jones MP, Dilley JB, Drossman D, Crowell MD. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil. 2006;18:91-103. [PMID: 16420287 DOI: 10.1111/j.1365-2982.2005.00730.x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 166] [Article Influence: 13.3] [Reference Citation Analysis]
429 Vasant DH, Paine PA, Black CJ, Houghton LA, Everitt HA, Corsetti M, Agrawal A, Aziz I, Farmer AD, Eugenicos MP, Moss-Morris R, Yiannakou Y, Ford AC. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut 2021;70:1214-40. [PMID: 33903147 DOI: 10.1136/gutjnl-2021-324598] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
430 Pohl CS, Medland JE, Moeser AJ. Early-life stress origins of gastrointestinal disease: animal models, intestinal pathophysiology, and translational implications. Am J Physiol Gastrointest Liver Physiol 2015;309:G927-41. [PMID: 26451004 DOI: 10.1152/ajpgi.00206.2015] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
431 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012. 18.3.258] [Reference Citation Analysis]
432 Spiller R, Major G. IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13:613-621. [PMID: 27667579 DOI: 10.1038/nrgastro.2016.141] [Cited by in Crossref: 70] [Cited by in F6Publishing: 56] [Article Influence: 17.5] [Reference Citation Analysis]
433 Friesen C, Singh M, Singh V, Schurman JV. A cross-sectional study of nausea in functional abdominal pain: relation to mucosal mast cells and psychological functioning. BMC Gastroenterol 2020;20:144. [PMID: 32393272 DOI: 10.1186/s12876-020-01291-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
434 Wang C, Fang X. Inflammation and Overlap of Irritable Bowel Syndrome and Functional Dyspepsia. J Neurogastroenterol Motil 2021;27:153-64. [PMID: 33795538 DOI: 10.5056/jnm20175] [Reference Citation Analysis]
435 Smith F, Clark JE, Overman BL, Tozel CC, Huang JH, Rivier JE, Blikslager AT, Moeser AJ. Early weaning stress impairs development of mucosal barrier function in the porcine intestine. Am J Physiol Gastrointest Liver Physiol. 2010;298:G352-G363. [PMID: 19926814 DOI: 10.1152/ajpgi.00081.2009] [Cited by in Crossref: 227] [Cited by in F6Publishing: 187] [Article Influence: 18.9] [Reference Citation Analysis]
436 Spiller R. Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res 2016;5:F1000 Faculty Rev-780. [PMID: 27158477 DOI: 10.12688/f1000research.7992.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
437 Piche T, Ducrotté P, Sabate JM, Coffin B, Zerbib F, Dapoigny M, Hua M, Marine-Barjoan E, Dainese R, Hébuterne X. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:626-e174. [PMID: 20403099 DOI: 10.1111/j.1365-2982.2010.01502.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.2] [Reference Citation Analysis]
438 Wang GD, Wang XY, Liu S, Qu M, Xia Y, Needleman BJ, Mikami DJ, Wood JD. Innervation of enteric mast cells by primary spinal afferents in guinea pig and human small intestine. Am J Physiol Gastrointest Liver Physiol 2014;307:G719-31. [PMID: 25147231 DOI: 10.1152/ajpgi.00125.2014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
439 Mai L, Liu Q, Huang F, He H, Fan W. Involvement of Mast Cells in the Pathophysiology of Pain. Front Cell Neurosci 2021;15:665066. [PMID: 34177465 DOI: 10.3389/fncel.2021.665066] [Reference Citation Analysis]
440 Grundy D, Schemann M. Enteric nervous system. Curr Opin Gastroenterol. 2005;21:176-182. [PMID: 15711209 DOI: 10.1097/01.mog.0000153315.28327.6e] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
441 Wood JD. Cellular Neurophysiology of Enteric Neurons. Physiology of the Gastrointestinal Tract. Elsevier; 2006. pp. 629-63. [DOI: 10.1016/b978-012088394-3/50026-x] [Cited by in Crossref: 10] [Article Influence: 0.7] [Reference Citation Analysis]
442 Murch S. Allergy and intestinal dysmotility – evidence of genuine causal linkage?: . Current Opinion in Gastroenterology 2006;22:664-8. [DOI: 10.1097/01.mog.0000245546.18279.7e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
443 Hamilton MJ, Frei SM, Stevens RL. The multifaceted mast cell in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:2364-2378. [PMID: 25401721 DOI: 10.1097/MIB.0000000000000142] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
444 Olén O, Neuman Å, Koopmann B, Ludvigsson JF, Ballardini N, Westman M, Melén E, Kull I, Simrén M, Bergström A. Allergy-related diseases and recurrent abdominal pain during childhood - a birth cohort study. Aliment Pharmacol Ther 2014;40:1349-58. [PMID: 25270840 DOI: 10.1111/apt.12965] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
445 Wood JD. Nonruminant Nutrition Symposium: Neurogastroenterology and food allergies. J Anim Sci 2012;90:1213-23. [PMID: 22100595 DOI: 10.2527/jas.2011-4787] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
446 Lee BJ, Bak YT. Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil. 2011;17:252-266. [PMID: 21860817 DOI: 10.5056/jnm.2011.17.3.252] [Cited by in Crossref: 103] [Cited by in F6Publishing: 84] [Article Influence: 10.3] [Reference Citation Analysis]
447 Parkes GC, Brostoff J, Whelan K, Sanderson JD. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment. Am J Gastroenterol. 2008;103:1557-1567. [PMID: 18513268 DOI: 10.1111/j.1572-0241.2008.01869.x] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 8.0] [Reference Citation Analysis]
448 Gwee KA. Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia. J Neurogastroenterol Motil. 2010;16:30-34. [PMID: 20535323 DOI: 10.5056/jnm.2010.16.1.30] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
449 Hamilton MJ. Nonclonal Mast Cell Activation Syndrome: A Growing Body of Evidence. Immunol Allergy Clin North Am 2018;38:469-81. [PMID: 30007464 DOI: 10.1016/j.iac.2018.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
450 Knowles CH, Lindberg G, Panza E, De Giorgio R. New perspectives in the diagnosis and management of enteric neuropathies. Nat Rev Gastroenterol Hepatol. 2013;10:206-218. [PMID: 23399525 DOI: 10.1038/nrgastro.2013.18] [Cited by in Crossref: 75] [Cited by in F6Publishing: 59] [Article Influence: 9.4] [Reference Citation Analysis]
451 Vivinus-nébot M, Frin-mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation. Gut 2014;63:744-52. [DOI: 10.1136/gutjnl-2012-304066] [Cited by in Crossref: 187] [Cited by in F6Publishing: 180] [Article Influence: 23.4] [Reference Citation Analysis]
452 Mearin F, Perez-Oliveras M, Perello A, Vinyet J, Ibanez A, Coderch J, Perona M. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology. 2005;129:98-104. [PMID: 16012939 DOI: 10.1053/j.gastro.2005.04.012] [Cited by in Crossref: 270] [Cited by in F6Publishing: 224] [Article Influence: 16.9] [Reference Citation Analysis]
453 Hughes PA, Brierley SM, Blackshaw LA. Post-inflammatory modification of colonic afferent mechanosensitivity. Clin Exp Pharmacol Physiol. 2009;36:1034-1040. [PMID: 19566823 DOI: 10.1111/j.1440-1681.2009.05248.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
454 Stanghellini V. Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV. Dig Dis. 2017;35 Suppl 1:14-17. [PMID: 29421792 DOI: 10.1159/000485408] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
455 Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterology. 2005;129:1060-1078. [PMID: 16143143 DOI: 10.1053/j.gastro.2005.06.062] [Cited by in Crossref: 96] [Cited by in F6Publishing: 66] [Article Influence: 6.0] [Reference Citation Analysis]
456 Wouters MM, Vicario M, Santos J. The role of mast cells in functional GI disorders. Gut. 2016;65:155-168. [PMID: 26194403 DOI: 10.1136/gutjnl-2015-309151] [Cited by in Crossref: 147] [Cited by in F6Publishing: 133] [Article Influence: 24.5] [Reference Citation Analysis]
457 Moleski SM, Choudhary C. Special considerations for women with IBD. Gastroenterol Clin North Am 2011;40:387-98, viii-ix. [PMID: 21601786 DOI: 10.1016/j.gtc.2011.03.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
458 Kim DH, Cho YJ, Kim JH, Kim YB, Lee KJ. Stress-induced alterations in mast cell numbers and proteinase-activated receptor-2 expression of the colon: role of corticotrophin-releasing factor. J Korean Med Sci. 2010;25:1330-1335. [PMID: 20808677 DOI: 10.3346/jkms.2010.25.9.1330] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
459 Ohman L, Lindmark AC, Isaksson S, Posserud I, Strid H, Sjövall H, Simrén M. Increased TLR2 expression on blood monocytes in irritable bowel syndrome patients. Eur J Gastroenterol Hepatol 2012;24:398-405. [PMID: 22273988 DOI: 10.1097/MEG.0b013e3283503f39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.1] [Reference Citation Analysis]
460 Lomax AE, Fernández E, Sharkey KA. Plasticity of the enteric nervous system during intestinal inflammation. Neurogastroenterol Motil. 2005;17:4-15. [PMID: 15670258 DOI: 10.1111/j.1365-2982.2004.00607.x] [Cited by in Crossref: 124] [Cited by in F6Publishing: 112] [Article Influence: 7.8] [Reference Citation Analysis]
461 Crowell MD, Harris L, Jones MP, Chang L. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep. 2005;7:272-279. [PMID: 16042910 DOI: 10.1007/s11894-005-0019-8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
462 Eutamene H, Lamine F, Chabo C, Theodorou V, Rochat F, Bergonzelli GE, Corthésy-Theulaz I, Fioramonti J, Bueno L. Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats. J Nutr 2007;137:1901-7. [PMID: 17634262 DOI: 10.1093/jn/137.8.1901] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 6.8] [Reference Citation Analysis]
463 Mearin F, Perelló A, Balboa A, Perona M, Sans M, Salas A, Angulo S, Lloreta J, Benasayag R, García-gonzalez MA, Pérez-oliveras M, Coderch J. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: Results 3 years after gastroenteritis. Scandinavian Journal of Gastroenterology 2009;44:1173-85. [DOI: 10.1080/00365520903171276] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
464 Shea-Donohue T, Cook IJ, de Giorgio R, Tonini M, Dent J, Costa M, Grundy D, Sanders KM, Schemann M, Smith TK. A teaching module on irritable bowel syndrome. Neurogastroenterol Motil. 2005;17 Suppl 3:20-40. [PMID: 16137318 DOI: 10.1111/j.1365-2982.2005.00713.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
465 Mayer EA, Bradesi S, Chang L, Spiegel BM, Bueller JA, Naliboff BD. Functional GI disorders: from animal models to drug development. Gut. 2008;57:384-404. [PMID: 17965064 DOI: 10.1136/gut.2006.101675] [Cited by in Crossref: 116] [Cited by in F6Publishing: 111] [Article Influence: 8.3] [Reference Citation Analysis]
466 Whorwell PJ, Altringer L, Morel J, Bond Y, Charbonneau D, O'Mahony L, Kiely B, Shanahan F, Quigley EM. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581-1590. [PMID: 16863564 DOI: 10.1111/j.1572-0241.2006.00734.x] [Cited by in Crossref: 521] [Cited by in F6Publishing: 419] [Article Influence: 34.7] [Reference Citation Analysis]
467 Domagala M, Laplagne C, Leveque E, Laurent C, Fournié JJ, Espinosa E, Poupot M. Cancer Cells Resistance Shaping by Tumor Infiltrating Myeloid Cells. Cancers (Basel) 2021;13:E165. [PMID: 33418996 DOI: 10.3390/cancers13020165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
468 D'Costa S, Ayyadurai S, Gibson AJ, Mackey E, Rajput M, Sommerville LJ, Wilson N, Li Y, Kubat E, Kumar A, Subramanian H, Bhargava A, Moeser AJ. Mast cell corticotropin-releasing factor subtype 2 suppresses mast cell degranulation and limits the severity of anaphylaxis and stress-induced intestinal permeability. J Allergy Clin Immunol 2019;143:1865-1877.e4. [PMID: 30439403 DOI: 10.1016/j.jaci.2018.08.053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
469 Mahurkar-Joshi S, Rankin CR, Videlock EJ, Soroosh A, Verma A, Khandadash A, Iliopoulos D, Pothoulakis C, Mayer EA, Chang L. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling. Gastroenterology 2021;160:2409-2422.e19. [PMID: 33617890 DOI: 10.1053/j.gastro.2021.02.040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
470 Bertrand J, Ghouzali I, Guérin C, Bôle-feysot C, Gouteux M, Déchelotte P, Ducrotté P, Coëffier M. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome. JPEN J Parenter Enteral Nutr 2016;40:1170-6. [DOI: 10.1177/0148607115587330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
471 Mondelaers SU, Theofanous SA, Florens MV, Perna E, Aguilera-Lizarraga J, Boeckxstaens GE, Wouters MM. Effect of genetic background and postinfectious stress on visceral sensitivity in Citrobacter rodentium-infected mice. Neurogastroenterol Motil 2016;28:647-58. [PMID: 26728091 DOI: 10.1111/nmo.12759] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
472 Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. [PMID: 28274109 DOI: 10.5056/jnm16214] [Cited by in Crossref: 216] [Cited by in F6Publishing: 128] [Article Influence: 54.0] [Reference Citation Analysis]
473 Verdu EF, Collins SM. Irritable bowel syndrome and probiotics: from rationale to clinical use: . Current Opinion in Gastroenterology 2005;21:697-701. [DOI: 10.1097/01.mog.0000182861.11669.4d] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
474 Asadi-shahmirzadi A, Mozaffari S, Sanei Y, Baeeri M, Hajiaghaee R, Monsef-esfahani HR, Abdollahi M. Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects. Chin J Integr Med . [DOI: 10.1007/s11655-012-1027-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
475 Akhavein M A, Patel NR, Muniyappa PK, Glover SC. Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility. Gastroenterol Res Pract 2012;2012:950582. [PMID: 22577375 DOI: 10.1155/2012/950582] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
476 Furness JB. The enteric nervous system: normal functions and enteric neuropathies. Neurogastroenterol Motil. 2008;20 Suppl 1:32-38. [PMID: 18402640 DOI: 10.1111/j.1365-2982.2008.01094.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 8.2] [Reference Citation Analysis]
477 Jadrešin O, Hojsak I, Mišak Z, Kekez AJ, Trbojević T, Ivković L, Kolaček S. Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study. Journal of Pediatric Gastroenterology & Nutrition 2017;64:925-9. [DOI: 10.1097/mpg.0000000000001478] [Cited by in Crossref: 25] [Cited by in F6Publishing: 13] [Article Influence: 6.3] [Reference Citation Analysis]
478 Aerssens J, Camilleri M, Talloen W, Thielemans L, Göhlmann HW, Van Den Wyngaert I, Thielemans T, De Hoogt R, Andrews CN, Bharucha AE, Carlson PJ, Busciglio I, Burton DD, Smyrk T, Urrutia R, Coulie B. Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2008;6:194-205. [PMID: 18237869 DOI: 10.1016/j.cgh.2007.11.012] [Cited by in Crossref: 87] [Cited by in F6Publishing: 85] [Article Influence: 6.7] [Reference Citation Analysis]
479 Bennet SM, Keshteli AH, Bercik P, Madsen KL, Reed D, Vanner SJ. Application of metabolomics to the study of irritable bowel syndrome. Neurogastroenterol Motil 2020;32:e13884. [PMID: 32426922 DOI: 10.1111/nmo.13884] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
480 Cuomo R, Savarese MF, Gargano R. Almost All Irritable Bowel Syndromes Are Post-Infectious and Respond to Probiotics: Consensus Issues. Dig Dis 2007;25:241-4. [DOI: 10.1159/000103893] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
481 van der veek PPJ, steenvoorden M, steens J, van der schaar PJ, brussee J, masclee AAM. Recto-colonic reflex is impaired in patients with irritable bowel syndrome. Neurogastroenterol Motil 2007;19:653-9. [DOI: 10.1111/j.1365-2982.2007.00921.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
482 Graziottin A. Perception of chronic pelvic pain in women: predictors and clinical implications. Urologia 2008;75:67-74. [DOI: 10.1177/039156030807500202] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
483 Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288-1294. [PMID: 16771951 DOI: 10.1111/j.1572-0241.2006.00672.x] [Cited by in Crossref: 311] [Cited by in F6Publishing: 298] [Article Influence: 20.7] [Reference Citation Analysis]
484 Liu DR, Xu XJ, Yao SK. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol. 2018;24:46-57. [PMID: 29358881 DOI: 10.3748/wjg.v24.i1.46] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
485 Katsinelos P, Lazaraki G, Kountouras J, Paroutoglou G, Oikonomidou I, Mimidis K, Koutras C, Gelas G, Tziomalos K, Zavos C. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece. Eur J Gastroenterol Hepatol. 2009;21:183-189. [PMID: 19212207 DOI: 10.1097/MEG.0b013e328312eb97] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
486 Wood JD. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology. 2004;127:635-657. [PMID: 15300595 DOI: 10.1053/j.gastro.2004.02.017] [Cited by in Crossref: 137] [Cited by in F6Publishing: 127] [Article Influence: 8.1] [Reference Citation Analysis]
487 Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-1359. [PMID: 26444549 DOI: 10.1111/eci.12548] [Cited by in Crossref: 47] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
488 Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: A randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28:1533-1544. [PMID: 27154424 DOI: 10.1111/nmo.12851] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
489 Meira de-Faria F, Casado-Bedmar M, Mårten Lindqvist C, Jones MP, Walter SA, Keita ÅV. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Neurogastroenterol Motil 2021;:e14130. [PMID: 33797165 DOI: 10.1111/nmo.14130] [Reference Citation Analysis]
490 Muehler A, Slizgi JR, Kohlhof H, Groeppel M, Peelen E, Vitt D. Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases. World J Gastrointest Pathophysiol 2020;11:114-30. [PMID: 33362939 DOI: 10.4291/wjgp.v11.i6.114] [Reference Citation Analysis]
491 Bashashati M, Moossavi S, Cremon C, Barbaro MR, Moraveji S, Talmon G, Rezaei N, Hughes PA, Bian ZX, Choi CH, Lee OY, Coëffier M, Chang L, Ohman L, Schmulson MJ, Mccallum RW, Simren M, Sharkey KA, Barbara G. Colonic immune cells in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2018;30:e13192. [DOI: 10.1111/nmo.13192] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 13.5] [Reference Citation Analysis]
492 Weinstock LB, Fern SE, Duntley SP. Restless legs syndrome in patients with irritable bowel syndrome: response to small intestinal bacterial overgrowth therapy. Dig Dis Sci. 2008;53:1252-1256. [PMID: 17934858 DOI: 10.1007/s10620-007-0021-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
493 Knowles CH. New horizons in the pathogenesis of gastrointestinal neuromuscular disease. J Pediatr Gastroenterol Nutr 2007;45 Suppl 2:S97-102. [PMID: 18185077 DOI: 10.1097/MPG.0b013e31812e6569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
494 Barbara G. Mucosal barrier defects in irritable bowel syndrome. Who left the door open? Am J Gastroenterol. 2006;101:1295-1298. [PMID: 16771952 DOI: 10.1111/j.1572-0241.2006.00667.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
495 van Kessel L, Teunissen D, Lagro-Janssen T. Sex-Gender Differences in the Effectiveness of Treatment of Irritable Bowel Syndrome: A Systematic Review. Int J Gen Med 2021;14:867-84. [PMID: 33758534 DOI: 10.2147/IJGM.S291964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Robles A, Perez Ingles D, Myneedu K, Deoker A, Sarosiek I, Zuckerman MJ, Schmulson MJ, Bashashati M. Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2019;31:e13718. [PMID: 31498961 DOI: 10.1111/nmo.13718] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
497 Saad RJ, Chey WD. Recent developments in the therapy of irritable bowel syndrome. Expert Opinion on Investigational Drugs 2008;17:117-30. [DOI: 10.1517/13543784.17.2.117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
498 Gracie DJ, Ford AC. IBS-like symptoms in patients with ulcerative colitis. Clin Exp Gastroenterol. 2015;8:101-109. [PMID: 25733921 DOI: 10.2147/ceg.s58153] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
499 Watier A, Labat J-, Robert R, Riant T, Guérineau M. Physiopathologie des douleurs pelvi-périnéales. Douleur analg 2007;20:117-27. [DOI: 10.1007/s11724-007-0048-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
500 Tanaka Y, Kanazawa M, Fukudo S, Drossman DA. Biopsychosocial model of irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:131-139. [PMID: 21602989 DOI: 10.5056/jnm.2011.17.2.13] [Reference Citation Analysis]
501 Powell N, Walker MM, Talley NJ. Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol. 2010;7:146-156. [PMID: 20125092 DOI: 10.1038/nrgastro.2010.5] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 6.2] [Reference Citation Analysis]
502 Shayto RH, Abou Mrad R, Sharara AI. Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol 2016;22:6638-51. [PMID: 27547007 DOI: 10.3748/wjg.v22.i29.6638] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
503 Mittal A, Sagi V, Gupta M, Gupta K. Mast Cell Neural Interactions in Health and Disease. Front Cell Neurosci 2019;13:110. [PMID: 30949032 DOI: 10.3389/fncel.2019.00110] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
504 Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41:850-853. [PMID: 19740713 DOI: 10.1016/j.dld.2009.07.023] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
505 Chang HC, Yen AM, Fann JC, Chiu SY, Liao CS, Chen HH, Yang KC, Chen LS, Lin YM. Irritable bowel syndrome and the incidence of colorectal neoplasia: a prospective cohort study with community-based screened population in Taiwan. Br J Cancer 2015;112:171-6. [PMID: 25474251 DOI: 10.1038/bjc.2014.575] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
506 Yu Y, Daly DM, Adam IJ, Kitsanta P, Hill CJ, Wild J, Shorthouse A, Grundy D, Jiang W. Interplay between mast cells, enterochromaffin cells, and sensory signaling in the aging human bowel. Neurogastroenterol Motil 2016;28:1465-79. [PMID: 27206689 DOI: 10.1111/nmo.12842] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
507 Kamiya T, Shikano M, Tanaka M, Ozeki K, Ebi M, Katano T, Hamano S, Nishiwaki H, Tsukamoto H, Mizoshita T, Mori Y, Kubota E, Tanida S, Kataoka H, Okuda N, Joh T. Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study. Evid Based Complement Alternat Med 2014;2014:828137. [PMID: 25161692 DOI: 10.1155/2014/828137] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
508 Cenac N. Protease-activated receptors as therapeutic targets in visceral pain. Curr Neuropharmacol. 2013;11:598-605. [PMID: 24396336 DOI: 10.2174/1570159x113119990039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
509 van Diest SA, Stanisor OI, Boeckxstaens GE, de Jonge WJ, van den Wijngaard RM. Relevance of mast cell-nerve interactions in intestinal nociception. Biochim Biophys Acta 2012;1822:74-84. [PMID: 21496484 DOI: 10.1016/j.bbadis.2011.03.019] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
510 Akbar A, Walters JR, Ghosh S. Review article: visceral hypersensitivity in irritable bowel syndrome: molecular mechanisms and therapeutic agents. Aliment Pharmacol Ther. 2009;30:423-435. [PMID: 19493256 DOI: 10.1111/j.1365-2036.2009.04056.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
511 Mcmahon SB, Russa FL, Bennett DLH. Crosstalk between the nociceptive and immune systems in host defence and disease. Nat Rev Neurosci 2015;16:389-402. [DOI: 10.1038/nrn3946] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 17.2] [Reference Citation Analysis]
512 Friesen CA, Schurman JV, Colombo JM, Abdel-Rahman SM. Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther. 2013;4:86-96. [PMID: 24199024 DOI: 10.4292/wjgpt.v4.i4.86] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
513 Lin L, Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18:2. [PMID: 28061847 DOI: 10.1186/s12865-016-0187-3] [Cited by in Crossref: 231] [Cited by in F6Publishing: 181] [Article Influence: 57.8] [Reference Citation Analysis]
514 Wood JD. Effects of bacteria on the enteric nervous system: implications for the irritable bowel syndrome. J Clin Gastroenterol 2007;41 Suppl 1:S7-19. [PMID: 17438418 DOI: 10.1097/MCG.0b013e31802f1331] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
515 O'brien AJ, Lamb EJ, Muller AF. Renal tubular proteinuria in patients with irritable bowel syndrome: . European Journal of Gastroenterology & Hepatology 2005;17:69-72. [DOI: 10.1097/00042737-200501000-00014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
516 Collins SM, Barbara G. East meets West: infection, nerves, and mast cells in the irritable bowel syndrome. Gut. 2004;53:1068-1069. [PMID: 15247169 DOI: 10.1136/gut.2004.038893] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
517 Anand P, Aziz Q, Willert R, van Oudenhove L. Peripheral and central mechanisms of visceral sensitization in man. Neurogastroenterol Motil. 2007;19:29-46. [PMID: 17280584 DOI: 10.1111/j.1365-2982.2006.00873.x] [Cited by in Crossref: 133] [Cited by in F6Publishing: 111] [Article Influence: 9.5] [Reference Citation Analysis]
518 Nee J, Zakari M, Lembo AJ. Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Expert Opin Pharmacother 2015;16:2781-92. [PMID: 26558923 DOI: 10.1517/14656566.2015.1101449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
519 Kim YS, Lee MY, Ryu HS, Choi ES, Oh JT, Yun KJ, Choi SC. Regional Differences in Chronic Stress-induced Alterations in Mast Cell and Protease-activated Receptor-2-positive Cell Numbers in the Colon of Ws/Ws Rats. J Neurogastroenterol Motil 2014;20:54-63. [PMID: 24466445 DOI: 10.5056/jnm.2014.20.1.54] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
520 Spiller R. Serotonin, inflammation, and IBS: fitting the jigsaw together? J Pediatr Gastroenterol Nutr. 2007;45 Suppl 2:S115-S119. [PMID: 18185071 DOI: 10.1097/mpg.0b013e31812e66da] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
521 Coldwell JR, Phillis BD, Sutherland K, Howarth GS, Blackshaw LA. Increased responsiveness of rat colonic splanchnic afferents to 5-HT after inflammation and recovery. J Physiol. 2007;579:203-213. [PMID: 17138606 DOI: 10.1113/jphysiol.2006.123158] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
522 van Diest SA, van den Elsen LW, Klok AJ, Welting O, Hilbers FW, van de Heijning BJ, Gaemers IC, Boeckxstaens GE, Werner MF, Willemsen LE, de Jonge WJ, van den Wijngaard RM. Dietary Marine n-3 PUFAs Do Not Affect Stress-Induced Visceral Hypersensitivity in a Rat Maternal Separation Model. J Nutr 2015;145:915-22. [PMID: 25716554 DOI: 10.3945/jn.114.201731] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
523 Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M, Blandizzi C. Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 2008;120:233-53. [PMID: 18848843 DOI: 10.1016/j.pharmthera.2008.08.010] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 6.7] [Reference Citation Analysis]
524 Tsai J, Wang I, Shen T, Lin C, Wei C. A 8-year population-based cohort study of irritable bowel syndrome in childhood with history of atopic dermatitis. J Investig Med 2018;66:755-61. [DOI: 10.1136/jim-2017-000631] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
525 Pinn DM, Aroniadis OC, Brandt LJ. Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? Neurogastroenterol Motil. 2015;27:19-29. [PMID: 25424663 DOI: 10.1111/nmo.12479] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 7.7] [Reference Citation Analysis]
526 Taylor TJ, Youssef NN, Shankar R, Kleiner DE, Henderson WA. The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. BMC Res Notes. 2010;3:265. [PMID: 20964845 DOI: 10.1186/1756-0500-3-265] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
527 Barbara G, Cremon C, Carini G, Bellacosa L, Zecchi L, De Giorgio R, Corinaldesi R, Stanghellini V. The immune system in irritable bowel syndrome. J Neurogastroenterol Motil. 2011;17:349-359. [PMID: 22148103 DOI: 10.5056/jnm.2011.17.4.349] [Cited by in Crossref: 119] [Cited by in F6Publishing: 102] [Article Influence: 11.9] [Reference Citation Analysis]
528 Gong L, Li J, Tang Y, Han T, Wei C, Yu X, Li J, Wang R, Ma X, Liu K, Geng L, Liu S, Yan B, Liu C. The antinociception of oxytocin on colonic hypersensitivity in rats was mediated by inhibition of mast cell degranulation via Ca(2+)-NOS pathway. Sci Rep 2016;6:31452. [PMID: 27538454 DOI: 10.1038/srep31452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
529 Cryan JF, O'riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, Codagnone MG, Cussotto S, Fulling C, Golubeva AV, Guzzetta KE, Jaggar M, Long-smith CM, Lyte JM, Martin JA, Molinero-perez A, Moloney G, Morelli E, Morillas E, O'connor R, Cruz-pereira JS, Peterson VL, Rea K, Ritz NL, Sherwin E, Spichak S, Teichman EM, van de Wouw M, Ventura-silva AP, Wallace-fitzsimons SE, Hyland N, Clarke G, Dinan TG. The Microbiota-Gut-Brain Axis. Physiological Reviews 2019;99:1877-2013. [DOI: 10.1152/physrev.00018.2018] [Cited by in Crossref: 551] [Cited by in F6Publishing: 408] [Article Influence: 275.5] [Reference Citation Analysis]
530 Traina G, Cocchi M. Mast cells in the brain – Old cells, new target. JIN 2017;16:S69-83. [DOI: 10.3233/jin-170068] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
531 Kugler EM, Mazzuoli G, Demir IE, Ceyhan GO, Zeller F, Schemann M. Activity of protease-activated receptors in primary cultured human myenteric neurons. Front Neurosci. 2012;6:133. [PMID: 22988431 DOI: 10.3389/fnins.2012.00133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
532 Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF. A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D). Gut. 2016;65:91-99. [PMID: 25765462 DOI: 10.1136/gutjnl-2015-309122] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
533 La JH, Gebhart GF. Condition-specific role of colonic inflammatory molecules in persistent functional colorectal hypersensitivity in the mouse. Neurogastroenterol Motil 2014;26:1730-42. [PMID: 25307695 DOI: 10.1111/nmo.12455] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
534 Grundy L, Brierley SM. Cross-organ sensitization between the colon and bladder: to pee or not to pee? Am J Physiol Gastrointest Liver Physiol 2018;314:G301-8. [PMID: 29146678 DOI: 10.1152/ajpgi.00272.2017] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
535 rka R, wittmann T, bueno L. Altered protease signalling in the gut: a novel pathophysiological factor in irritable bowel syndrome. Neurogastroenterology & Motility 2008;20:853-6. [DOI: 10.1111/j.1365-2982.2008.01155.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
536 Barbara G. Toll-Like Receptor Expression in Irritable Bowel Syndrome: On the Alert for a Microbial Threat? American Journal of Gastroenterology 2011;106:337-9. [DOI: 10.1038/ajg.2010.440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
537 Piche T. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome]. Gastroenterol Clin Biol. 2009;33 Suppl 1:S40-S47. [PMID: 19303538 DOI: 10.1016/S0399-8320(09)71524-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
538 Nasser Y, Boeckxstaens GE, Wouters MM, Schemann M, Vanner S. Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:455-469. [PMID: 24602069 DOI: 10.1111/nmo.12316] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 5.4] [Reference Citation Analysis]
539 Whorwell PJ. Do probiotics improve symptoms in patients with irritable bowel syndrome? Ther Adv Gastroenterol. 2009;2:S37-S44. [PMID: 21180553 DOI: 10.1177/1756283x09335637] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
540 Zucchelli M, Camilleri M, Andreasson AN, Bresso F, Dlugosz A, Halfvarson J, Törkvist L, Schmidt PT, Karling P, Ohlsson B. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut. 2011;60:1671-1677. [PMID: 21636646 DOI: 10.1136/gut.2011.241877] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 9.0] [Reference Citation Analysis]
541 Spiller R, Bennett A. Searching for the Answer to Irritable Bowel Syndrome in the Colonic Mucosa: SERTainty and UnSERTainty. Gastroenterology 2007;132:437-41. [DOI: 10.1053/j.gastro.2006.12.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
542 Velasco-benítez CA, Ortíz-rivera CJ. ¿El antecedente de dengue está asociado a la presencia de Desórdenes Gastrointestinales Funcionales en Niños? Infect 2019;23:161. [DOI: 10.22354/in.v23i2.773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
543 Scalera A, Di Minno MN, Tarantino G. What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol. 2013;19:5402-5420. [PMID: 24023483 DOI: 10.3748/wjg.v19.i33.5402] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
544 Chang L, Sundaresh S, Elliott J, Anton PA, Baldi P, Licudine A, Mayer M, Vuong T, Hirano M, Naliboff BD. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol Motil. 2009;21:149-159. [PMID: 18684212 DOI: 10.1111/j.1365-2982.2008.01171.x] [Cited by in Crossref: 153] [Cited by in F6Publishing: 149] [Article Influence: 11.8] [Reference Citation Analysis]
545 Vercellini P, Somigliana E, Viganò P, Abbiati A, Barbara G, Fedele L. Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach. Gynecological Endocrinology 2009;25:149-58. [DOI: 10.1080/09513590802549858] [Cited by in Crossref: 69] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
546 Collins SM. Dysregulation of peripheral cytokine production in irritable bowel syndrome. Am J Gastroenterol. 2005;100:2517-2518. [PMID: 16279908 DOI: 10.1111/j.1572-0241.2005.00246.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
547 Varma MG, Gurland BH. Constipation and Functional Bowel Disorders. In: Beck DE, Roberts PL, Saclarides TJ, Senagore AJ, Stamos MJ, Wexner SD, editors. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer; 2011. pp. 535-48. [DOI: 10.1007/978-1-4419-1584-9_32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
548 Song J, Zhang L, Bai T, Qian W, Li R, Hou X. Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome. J Neurogastroenterol Motil 2015;21:236-46. [PMID: 25843076 DOI: 10.5056/jnm14095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
549 Traini C, Evangelista S, Girod V, Faussone-Pellegrini MS, Vannucchi MG. Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress. J Cell Mol Med 2017;21:735-45. [PMID: 27866394 DOI: 10.1111/jcmm.13016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
550 Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Chae SW. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil. 2013;19:244-250. [PMID: 23667756 DOI: 10.5056/jnm.2013.19.2.244] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
551 Hellström PM. Pathophysiology of the irritable bowel syndrome - Reflections of today. Best Pract Res Clin Gastroenterol 2019;40-41:101620. [PMID: 31594651 DOI: 10.1016/j.bpg.2019.05.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
552 Xu W, Yuan M, Wu X, Geng H, Chen L, Zhou J, Song Y, Pei L, Sun J. Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome. Evid Based Complement Alternat Med 2018;2018:7048584. [PMID: 30420896 DOI: 10.1155/2018/7048584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
553 Sundin J, Nordlander S, Eutamene H, Alquier‐bacquie V, Cartier C, Theodorou V, Le Nevé B, Törnblom H, Simrén M, Öhman L. Colonic mast cell numbers, symptom profile, and mucosal expression of elements of the epithelial barrier in irritable bowel syndrome. Neurogastroenterology & Motility 2019;31. [DOI: 10.1111/nmo.13701] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
554 Di Nardo G, Barbara G, Cucchiara S, Cremon C, Shulman RJ, Isoldi S, Zecchi L, Drago L, Oliva S, Saulle R. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Neurogastroenterol Motil. 2014;26:196-204. [PMID: 24304324 DOI: 10.1111/nmo.12250] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
555 Quigley EM. Disturbances of motility and visceral hypersensitivity in irritable bowel syndrome: biological markers or epiphenomenon. Gastroenterol Clin North Am. 2005;34:221-233, vi. [PMID: 15862931 DOI: 10.1016/j.gtc.2005.02.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
556 Hoffman JM. Irritable bowel syndrome: is the colonic mucosa to blame? Neurogastroenterol Motil 2012;24:1051-3. [PMID: 23176660 DOI: 10.1111/nmo.12039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
557 Botschuijver S, van Diest SA, van Thiel IAM, Saia RS, Strik AS, Yu Z, Maria-Ferreira D, Welting O, Keszthelyi D, Jennings G, Heinsbroek SEM, Elferink RPO, Schuren FHJ, de Jonge WJ, van den Wijngaard RM. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms. Sci Rep 2019;9:12530. [PMID: 31467355 DOI: 10.1038/s41598-019-49096-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
558 Barbara G, Zecchi L, Barbaro R, Cremon C, Bellacosa L, Marcellini M, De Giorgio R, Corinaldesi R, Stanghellini V. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. J Clin Gastroenterol. 2012;46 Suppl:S52-S55. [PMID: 22955358 DOI: 10.1097/mcg.0b013e318264e918] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
559 Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005;17:281-9. [DOI: 10.1111/j.1365-2982.2004.00591.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.7] [Reference Citation Analysis]
560 Gebhardt T, Gerhard R, Bedoui S, Erpenbeck VJ, Hoffmann MW, Manns MP, Bischoff SC. beta2-Adrenoceptor-mediated suppression of human intestinal mast cell functions is caused by disruption of filamentous actin dynamics. Eur J Immunol 2005;35:1124-32. [PMID: 15756641 DOI: 10.1002/eji.200425869] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
561 Quigley EM. Probiotics in the management of functional bowel disorders: promise fulfilled? Gastroenterol Clin North Am 2012;41:805-19. [PMID: 23101688 DOI: 10.1016/j.gtc.2012.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
562 Benson S, Engler H, Schedlowski M, Elsenbruch S. Experimental endotoxemia as a model to study neuroimmune mechanisms in human visceral pain. Ann N Y Acad Sci 2012;1262:108-17. [PMID: 22823442 DOI: 10.1111/j.1749-6632.2012.06622.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
563 Chen JH, Wei SZ, Chen J, Wang Q, Liu HL, Gao XH, Li GC, Yu WZ, Chen M, Luo HS. Sensory denervation reduces visceral hypersensitivity in adult rats exposed to chronic unpredictable stress: evidences of neurogenic inflammation. Dig Dis Sci. 2009;54:1884-1891. [PMID: 19051028 DOI: 10.1007/s10620-008-0575-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
564 Camilleri M. Review article: new receptor targets for medical therapy in irritable bowel syndrome. Aliment Pharmacol Ther. 2010;31:35-46. [PMID: 19785622 DOI: 10.1111/j.1365-2036.2009.04153.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
565 Collins SM. The Relationship of Enteric Microbial Infection and Functional Bowel Disorders. Journal of Clinical Gastroenterology 2007;41:S30-2. [DOI: 10.1097/mcg.0b013e31802db351] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
566 Park JH, Rhee PL, Kim HS, Lee JH, Kim YH, Kim JJ, Rhee JC. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2006;21:71-78. [PMID: 16706815 DOI: 10.1111/j.1440-1746.2005.04143.x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 117] [Article Influence: 8.6] [Reference Citation Analysis]
567 Rudick CN, Schaeffer AJ, Klumpp DJ. Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol 2009;9:16. [PMID: 19909543 DOI: 10.1186/1471-2490-9-16] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
568 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm] [Cited by in Crossref: 21] [Article Influence: 4.2] [Reference Citation Analysis]
569 Quigley EM. Editorial: PARs for the Course: Roles of Proteases and PAR Receptors in Subtly Inflamed Irritable Bowel Syndrome: . American Journal of Gastroenterology 2013;108:1644-6. [DOI: 10.1038/ajg.2013.245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
570 Ierardi E, Losurdo G, Iannone A, Piscitelli D, Amoruso A, Barone M, Principi M, Pisani A, Di Leo A. Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored? Ann Gastroenterol. 2017;30:380-392. [PMID: 28655974 DOI: 10.20524/aog.2017.0165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
571 Vivinus-nébot M, Dainese R, Anty R, Saint-paul MC, Nano JL, Gonthier N, Marjoux S, Frin-mathy G, Bernard G, Hébuterne X, Tran A, Theodorou V, Piche T. Combination of Allergic Factors Can Worsen Diarrheic Irritable Bowel Syndrome: Role of Barrier Defects and Mast Cells. American Journal of Gastroenterology 2012;107:75-81. [DOI: 10.1038/ajg.2011.315] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 9.7] [Reference Citation Analysis]
572 Van Nassauw L, Adriaensen D, Timmermans JP. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci. 2007;133:91-103. [PMID: 17169619 DOI: 10.1016/j.autneu.2006.10.003] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
573 Liebregts T, Adam B, Bertel A, Jones S, Schulze J, Enders C, Sonnenborn U, Lackner K, Holtmann G. Effect of E. coli Nissle 1917 on post-inflammatory visceral sensory function in a rat model. Neurogastroenterol Motil. 2005;17:410-414. [PMID: 15916628 DOI: 10.1111/j.1365-2982.2005.00638.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
574 Sarna SK. Lessons Learnt from Post-Infectious IBS. Front Physiol. 2011;2:49. [PMID: 21897820 DOI: 10.2289/fphys.2011.00049.epub] [Reference Citation Analysis]
575 Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology. 2009;137:1425-1434. [PMID: 19596012 DOI: 10.1053/j.gastro.2009.07.005] [Cited by in Crossref: 225] [Cited by in F6Publishing: 214] [Article Influence: 18.8] [Reference Citation Analysis]
576 Stasi C, Bellini M, Costa F, Mumolo MG, Ricchiuti A, Grosso M, Duranti E, Metelli MR, Gambaccini D, Bianchi L. Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis. 2013;28:1203-1208. [PMID: 23377858 DOI: 10.1007/s00384-013-1646-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
577 Caffarelli C, Coscia A, Baldi F, Borghi A, Capra L, Cazzato S, Migliozzi L, Pecorari L, Valenti A, Cavagni G. Characterization of irritable bowel syndrome and constipation in children with allergic diseases. Eur J Pediatr 2007;166:1245-52. [PMID: 17345097 DOI: 10.1007/s00431-006-0410-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
578 Bassotti G, Villanacci V, Nascimbeni R, Cadei M, Manenti S, Sabatino G, Maurer CA, Cathomas G, Salerni B. Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther. 2011;34:92-99. [PMID: 21539589 DOI: 10.1111/j.1365-2036.2011.04684.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
579 Salari P, Abdollahi M. Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: is there hope? World J Gastroenterol 2011;17:4251-7. [PMID: 22090780 DOI: 10.3748/wjg.v17.i38.4251] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
580 Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil. 2006;18:595-607. [PMID: 16918724 DOI: 10.1111/j.1365-2982.2005.00745.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
581 Buhner S, Barki N, Greiter W, Giesbertz P, Demir IE, Ceyhan GO, Zeller F, Daniel H, Schemann M. Calcium Imaging of Nerve-Mast Cell Signaling in the Human Intestine. Front Physiol 2017;8:971. [PMID: 29238306 DOI: 10.3389/fphys.2017.00971] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
582 Cogliandro RF, Rizzoli G, Bellacosa L, De Giorgio R, Cremon C, Barbara G, Stanghellini V. Is gastroparesis a gastric disease? Neurogastroenterol Motil 2019;31:e13562. [PMID: 30773743 DOI: 10.1111/nmo.13562] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
583 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.1] [Reference Citation Analysis]
584 Bengtsson M, Hammar O, Mandl T, Ohlsson B. Evaluation of gastrointestinal symptoms in different patient groups using the visual analogue scale for irritable bowel syndrome (VAS-IBS). BMC Gastroenterol. 2011;11:122. [PMID: 22073983 DOI: 10.1186/1471-2393-13-201] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
585 Kim HS, Lim JH, Park H, Lee SI. Increased immunoendocrine cells in intestinal mucosa of postinfectious irritable bowel syndrome patients 3 years after acute Shigella infection--an observation in a small case control study. Yonsei Med J. 2010;51:45-51. [PMID: 20046513 DOI: 10.3349/ymj.2010.51.1.45] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
586 Pensabene L, Talarico V, Concolino D, Ciliberto D, Campanozzi A, Gentile T, Rutigliano V, Salvatore S, Staiano A, Di Lorenzo C, Graziano F, Palermo BV, Sanseviero M, Altomare F, Cozza E, Falvo A, Marseglia A, Gatta E, De Venuto D, Ripepi A, Turco R. Postinfectious Functional Gastrointestinal Disorders in Children: A Multicenter Prospective Study. The Journal of Pediatrics 2015;166:903-907.e1. [DOI: 10.1016/j.jpeds.2014.12.050] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
587 González-castro AM, Martínez C, Salvo-romero E, Fortea M, Pardo-camacho C, Pérez-berezo T, Alonso-cotoner C, Santos J, Vicario M. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome: Mucosal dysfunction in irritable bowel syndrome. Journal of Gastroenterology and Hepatology 2017;32:53-63. [DOI: 10.1111/jgh.13417] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
588 Rudick CN, Bryce PJ, Guichelaar LA, Berry RE, Klumpp DJ. Mast cell-derived histamine mediates cystitis pain. PLoS One 2008;3:e2096. [PMID: 18461160 DOI: 10.1371/journal.pone.0002096] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
589 Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review. Am J Gastroenterol. 2009;104:1033-1049; quiz 1050. [PMID: 19277023 DOI: 10.1038/ajg.2009.25] [Cited by in Crossref: 227] [Cited by in F6Publishing: 189] [Article Influence: 18.9] [Reference Citation Analysis]
590 Chatoo M, Li Y, Ma Z, Coote J, Du J, Chen X. Involvement of Corticotropin-Releasing Factor and Receptors in Immune Cells in Irritable Bowel Syndrome. Front Endocrinol (Lausanne) 2018;9:21. [PMID: 29483895 DOI: 10.3389/fendo.2018.00021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
591 Desormeaux C, Bautzova T, Garcia-Caraballo S, Rolland C, Barbaro MR, Brierley SM, Barbara G, Vergnolle N, Cenac N. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons. Pain 2018;159:1257-67. [PMID: 29554016 DOI: 10.1097/j.pain.0000000000001208] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
592 Barbaro MR, Di Sabatino A, Cremon C, Giuffrida P, Fiorentino M, Altimari A, Bellacosa L, Stanghellini V, Barbara G. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016;310:G439-47. [DOI: 10.1152/ajpgi.00368.2015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
593 Takagaki K, Osawa S, Horio Y, Yamada T, Hamaya Y, Takayanagi Y, Furuta T, Hishida A, Ikuma M. Cytokine responses of intraepithelial lymphocytes are regulated by histamine H2 receptor. J Gastroenterol 2009;44:285-96. [DOI: 10.1007/s00535-009-0019-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
594 Vergnolle N. Protease inhibition as new therapeutic strategy for GI diseases. Gut. 2016;65:1215-1224. [PMID: 27196587 DOI: 10.1136/gutjnl-2015-309147] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 18.2] [Reference Citation Analysis]
595 Larauche M. Novel insights in the role of peripheral corticotropin-releasing factor and mast cells in stress-induced visceral hypersensitivity. Neurogastroenterol Motil. 2012;24:201-205. [PMID: 22316289 DOI: 10.1111/j.1365-2982.2011.01867.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
596 Kellow JE, Azpiroz F, Delvaux M, Gebhart GF, Mertz HR, Quigley EM, Smout AJ. Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology. 2006;130:1412-1420. [PMID: 16678555 DOI: 10.1053/j.gastro.2005.08.061] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 4.9] [Reference Citation Analysis]
597 van den Wijngaard RM, Stanisor OI, van Diest SA, Welting O, Wouters MM, Cailotto C, de Jonge WJ, Boeckxstaens GE. Susceptibility to stress induced visceral hypersensitivity in maternally separated rats is transferred across generations. Neurogastroenterol Motil 2013;25:e780-90. [DOI: 10.1111/nmo.12202] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
598 Brierley SM, Hughes PA, Harrington AM, Rychkov GY, Blackshaw LA. Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain. Pharmaceuticals (Basel) 2010;3:2768-98. [PMID: 27713376 DOI: 10.3390/ph3092768] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
599 O'Malley D. Immunomodulation of enteric neural function in irritable bowel syndrome. World J Gastroenterol. 2015;21:7362-7366. [PMID: 26139983 DOI: 10.3748/wjg.v21.i24.7362] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
600 Kokkotou E, Conboy LA, Ziogas DC, Quilty MT, Kelley JM, Davis RB, Lembo AJ, Kaptchuk TJ. Serum correlates of the placebo effect in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:285-e81. [PMID: 20028464 DOI: 10.1111/j.1365-2982.2009.01440.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
601 Weinstock LB, Pace LA, Rezaie A, Afrin LB, Molderings GJ. Mast Cell Activation Syndrome: A Primer for the Gastroenterologist. Dig Dis Sci 2021;66:965-82. [PMID: 32328892 DOI: 10.1007/s10620-020-06264-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
602 Lobo B, Ramos L, Martínez C, Guilarte M, González-Castro AM, Alonso-Cotoner C, Pigrau M, de Torres I, Rodiño-Janeiro BK, Salvo-Romero E, Fortea M, Pardo-Camacho C, Guagnozzi D, Azpiroz F, Santos J, Vicario M. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study. United European Gastroenterol J 2017;5:887-97. [PMID: 29026603 DOI: 10.1177/2050640617691690] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
603 Kissel CL, Kovács KJ, Larson AA. Evidence for the modulation of nociception in mice by central mast cells. Eur J Pain 2017;21:1743-55. [PMID: 28722336 DOI: 10.1002/ejp.1086] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
604 Wood JD. Cellular Neurophysiology of Enteric Neurons. Physiology of the Gastrointestinal Tract. Elsevier; 2012. pp. 629-69. [DOI: 10.1016/b978-0-12-382026-6.00021-x] [Cited by in Crossref: 9] [Article Influence: 1.0] [Reference Citation Analysis]
605 Tanaka Y, Kanazawa M, Kano M, Tashiro M, Fukudo S. Relationship between sympathoadrenal and pituitary-adrenal response during colorectal distention in the presence of corticotropin-releasing hormone in patients with irritable bowel syndrome and healthy controls. PLoS One 2018;13:e0199698. [PMID: 29979696 DOI: 10.1371/journal.pone.0199698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
606 Sander LE, Lorentz A, Sellge G, Coëffier M, Neipp M, Veres T, Frieling T, Meier PN, Manns MP, Bischoff SC. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut. 2006;55:498-504. [PMID: 16299042 DOI: 10.1136/gut.2004.061762] [Cited by in Crossref: 104] [Cited by in F6Publishing: 92] [Article Influence: 6.5] [Reference Citation Analysis]
607 Ringel Y, Maharshak N. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2013;305:G529-G541. [PMID: 23886861 DOI: 10.1152/ajpgi.00207.2012] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 8.5] [Reference Citation Analysis]
608 Barbara G, Cremon C, De Giorgio R, Dothel G, Zecchi L, Bellacosa L, Carini G, Stanghellini V, Corinaldesi R. Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Curr Gastroenterol Rep. 2011;13:308-315. [PMID: 21537962 DOI: 10.1007/s11894-011-0195-7] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 6.9] [Reference Citation Analysis]
609 De Giorgio R, Volta U, Gibson PR. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction? Gut. 2016;65:169-178. [PMID: 26078292 DOI: 10.1136/gutjnl-2015-309757] [Cited by in Crossref: 112] [Cited by in F6Publishing: 90] [Article Influence: 18.7] [Reference Citation Analysis]
610 Benson S, Kattoor J, Wegner A, Hammes F, Reidick D, Grigoleit JS, Engler H, Oberbeck R, Schedlowski M, Elsenbruch S. Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans. Pain 2012;153:794-9. [PMID: 22264996 DOI: 10.1016/j.pain.2011.12.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 6.8] [Reference Citation Analysis]
611 Layer P. Management of irritable bowel syndrome with constipation: a flexible approach to treating a complex condition with multiple symptoms. Expert Review of Gastroenterology & Hepatology 2014;7:9-14. [DOI: 10.1586/17474124.2013.820049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
612 Vara EJ, Svanes C, Skorge TD, Berstad A, Florvaag E, Jarvis D, Omenaas E, Waatevik M, Johannessen A, Lied GA. Functional Gastrointestinal Symptoms Are Associated with Higher Serum Total IgE Levels, but Less Atopic Sensitization. Dig Dis Sci 2016;61:189-97. [DOI: 10.1007/s10620-015-3835-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
613 Surawicz CM. Mechanisms of diarrhea. Curr Gastroenterol Rep. 2010;12:236-241. [PMID: 20532705 DOI: 10.1007/s11894-010-0113-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
614 Buckley MM, O'Mahony SM, O'Malley D. Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol. 2014;20:8846-8858. [PMID: 25083058 DOI: 10.3748/wjg.v20.i27.8846] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
615 Ludidi S, Jonkers D, Elamin E, Pieters HJ, Schaepkens E, Bours P, Kruimel J, Conchillo J, Masclee A. The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model. PLoS One 2015;10:e0123498. [PMID: 25978614 DOI: 10.1371/journal.pone.0123498] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
616 Bassotti G, Villanacci V, Nascimbeni R, Antonelli E, Cadei M, Manenti S, Lorenzi L, Titi A, Salerni B. The role of colonic mast cells and myenteric plexitis in patients with diverticular disease. Int J Colorectal Dis 2013;28:267-72. [DOI: 10.1007/s00384-012-1554-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
617 Smith JL, Bayles D. Postinfectious irritable bowel syndrome: a long-term consequence of bacterial gastroenteritis. J Food Prot 2007;70:1762-9. [PMID: 17685356 DOI: 10.4315/0362-028x-70.7.1762] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
618 Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844-849. [PMID: 19716778 DOI: 10.1016/j.dld.2009.07.007] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
619 Fabisiak A, Włodarczyk J, Fabisiak N, Storr M, Fichna J. Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. J Neurogastroenterol Motil 2017;23:341-8. [PMID: 28551943 DOI: 10.5056/jnm16203] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
620 Wiet MG, Piscioneri A, Khan SN, Ballinger MN, Hoyland JA, Purmessur D. Mast Cell-Intervertebral disc cell interactions regulate inflammation, catabolism and angiogenesis in Discogenic Back Pain. Sci Rep 2017;7:12492. [PMID: 28970490 DOI: 10.1038/s41598-017-12666-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
621 Kim SE, Chang L. Overlap between functional GI disorders and other functional syndromes: what are the underlying mechanisms? Neurogastroenterol Motil. 2012;24:895-913. [PMID: 22863120 DOI: 10.1111/j.1365-2982.2012.01993.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 8.3] [Reference Citation Analysis]
622 Jacobson A, Yang D, Vella M, Chiu IM. The intestinal neuro-immune axis: crosstalk between neurons, immune cells, and microbes. Mucosal Immunol 2021;14:555-65. [PMID: 33542493 DOI: 10.1038/s41385-020-00368-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
623 Bueno L, de Ponti F, Fried M, Kullak-Ublick GA, Kwiatek MA, Pohl D, Quigley EM, Tack J, Talley NJ. Serotonergic and non-serotonergic targets in the pharmacotherapy of visceral hypersensitivity. Neurogastroenterol Motil. 2007;19:89-119. [PMID: 17280587 DOI: 10.1111/j.1365-2982.2006.00876.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
624 Principi N, Cozzali R, Farinelli E, Brusaferro A, Esposito S. Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics. J Infect 2018;76:111-20. [PMID: 29291933 DOI: 10.1016/j.jinf.2017.12.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
625 Camilleri M, Tack JF. Current medical treatments of dyspepsia and irritable bowel syndrome. Gastroenterol Clin North Am. 2010;39:481-493. [PMID: 20951913 DOI: 10.1016/j.gtc.2010.08.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
626 Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil. 2006;18:6-17. [PMID: 16371078 DOI: 10.1111/j.1365-2982.2005.00685.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
627 Buhner S, Schemann M. Mast cell–nerve axis with a focus on the human gut. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2012;1822:85-92. [DOI: 10.1016/j.bbadis.2011.06.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 9.2] [Reference Citation Analysis]
628 Cattaruzza F, Spreadbury I, Miranda-Morales M, Grady EF, Vanner S, Bunnett NW. Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice. Am J Physiol Gastrointest Liver Physiol. 2010;298:G81-G91. [PMID: 19875705 DOI: 10.1152/ajpgi.00221.2009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 84] [Article Influence: 7.0] [Reference Citation Analysis]
629 Ceuleers H, Hanning N, Heirbaut J, Van Remoortel S, Joossens J, Van Der Veken P, Francque SM, De Bruyn M, Lambeir AM, De Man JG, Timmermans JP, Augustyns K, De Meester I, De Winter BY. Newly developed serine protease inhibitors decrease visceral hypersensitivity in a post-inflammatory rat model for irritable bowel syndrome. Br J Pharmacol 2018;175:3516-33. [PMID: 29911328 DOI: 10.1111/bph.14396] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
630 Long X, Li M, Li LX, Sun YY, Zhang WX, Zhao DY, Li YQ. Butyrate promotes visceral hypersensitivity in an IBS-like model via enteric glial cell-derived nerve growth factor. Neurogastroenterol Motil. 2018;30:e13227. [PMID: 29052293 DOI: 10.1111/nmo.13227] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
631 Cuevas M, Cruz ML, Ramirez AE, Flores I, Thompson KJ, Bayona M, Vernon MW, Appleyard CB. Stress During Development of Experimental Endometriosis Influences Nerve Growth and Disease Progression. Reprod Sci 2018;25:347-57. [PMID: 29108503 DOI: 10.1177/1933719117737846] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
632 Spiller R, Campbell E. Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol. 2006;22:13-17. [PMID: 16319671 DOI: 10.1097/01.mog.0000194792.36466.5c] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.5] [Reference Citation Analysis]
633 Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1053-G1060. [PMID: 22323131 DOI: 10.1152/ajpgi.00153.2011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
634 Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246-1251. [PMID: 17932763 DOI: 10.1007/s10620-007-0022-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
635 Tonini M, Pace F. Drugs acting on serotonin receptors for the treatment of functional GI disorders. Dig Dis. 2006;24:59-69. [PMID: 16699264 DOI: 10.1159/000090309] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
636 Balemans D, Aguilera-lizarraga J, Florens MV, Jain P, Denadai-souza A, Viola MF, Alpizar YA, Van Der Merwe S, Vanden Berghe P, Talavera K, Vanner S, Wouters MM, Boeckxstaens GE. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019;316:G338-49. [DOI: 10.1152/ajpgi.00116.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
637 Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013;62:1160-1168. [PMID: 22637702 DOI: 10.1136/gutjnl-2012-302093] [Cited by in Crossref: 156] [Cited by in F6Publishing: 148] [Article Influence: 17.3] [Reference Citation Analysis]
638 Mujagic Z, Ludidi S, Keszthelyi D, Hesselink MAM, Kruimel JW, Lenaerts K, Hanssen NMJ, Conchillo JM, Jonkers DMAE, Masclee AAM. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacol Ther 2014;40:288-97. [DOI: 10.1111/apt.12829] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 9.6] [Reference Citation Analysis]
639 Cirillo C, Bessissow T, Desmet A, Vanheel H, Tack J, Vanden Berghe P. Evidence for Neuronal and Structural Changes in Submucous Ganglia of Patients With Functional Dyspepsia. American Journal of Gastroenterology 2015;110:1205-15. [DOI: 10.1038/ajg.2015.158] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 13.5] [Reference Citation Analysis]
640 Lam C, Tan W, Leighton M, Hastings M, Lingaya M, Falcone Y, Zhou X, Xu L, Whorwell P, Walls AF, Zaitoun A, Montgomery A, Spiller RC. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): a multicentre, parallel-group, randomised placebo-controlled trial. Efficacy Mech Eval 2015;2:1-62. [DOI: 10.3310/eme02020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
641 Han W, Wang Z, Lu X, Guo C. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:113-19, e82. [PMID: 22151913 DOI: 10.1111/j.1365-2982.2011.01841.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
642 Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016;9:7-17. [PMID: 26929659 DOI: 10.2147/ijgm.s93698] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
643 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
644 Kim GL, Yi YH, Hwang HR, Kim J, Park Y, Kim YJ, Lee JG, Tak YJ, Lee SH, Lee SY, Cho YH, Park EJ, Lee Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. J Clin Med 2021;10:2044. [PMID: 34068814 DOI: 10.3390/jcm10092044] [Reference Citation Analysis]
645 Bradesi S, Schwetz I, Ennes HS, Lamy CM, Ohning G, Fanselow M, Pothoulakis C, McRoberts JA, Mayer EA. Repeated exposure to water avoidance stress in rats: A new model for sustained visceral hyperalgesia. Am J Physiol Gastrointest Liver Physiol. 2005;289:G42-G53. [PMID: 15746211 DOI: 10.1152/ajpgi.00500.2004] [Cited by in Crossref: 178] [Cited by in F6Publishing: 175] [Article Influence: 11.1] [Reference Citation Analysis]
646 Lee JY, Kim N, Kim YS, Nam RH, Ham MH, Lee HS, Jo W, Shim Y, Choi YJ, Yoon H, Shin CM, Lee DH. Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats. J Neurogastroenterol Motil 2016;22:694-704. [PMID: 27466288 DOI: 10.5056/jnm16007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
647 Spiller R, Lam C. An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil. 2012;18:258-268. [PMID: 22837873 DOI: 10.5056/jnm.2012.18.3.258] [Cited by in Crossref: 98] [Cited by in F6Publishing: 87] [Article Influence: 10.9] [Reference Citation Analysis]
648 Stanghellini V, Cogliandro RF, De Giorgio R, Barbara G, Morselli-Labate AM, Cogliandro L, Corinaldesi R. Natural history of chronic idiopathic intestinal pseudo-obstruction in adults: a single center study. Clin Gastroenterol Hepatol. 2005;3:449-458. [PMID: 15880314 DOI: 10.1016/s1542-3565(04)00675-5] [Cited by in Crossref: 126] [Cited by in F6Publishing: 36] [Article Influence: 7.9] [Reference Citation Analysis]
649 Meyer N, Zenclussen AC. Mast cells-Good guys with a bad image? Am J Reprod Immunol 2018;80:e13002. [DOI: 10.1111/aji.13002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
650 Mujagic Z, Jonkers DMAE, Ludidi S, Keszthelyi D, Hesselink MA, Weerts ZZRM, Kievit RN, Althof JF, Leue C, Kruimel JW, van Schooten FJ, Masclee AAM. Biomarkers for visceral hypersensitivity in patients with irritable bowel syndrome. Neurogastroenterol Motil 2017;29. [PMID: 28675524 DOI: 10.1111/nmo.13137] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
651 Guilarte M, Vicario M, Martínez C, de Torres I, Lobo B, Pigrau M, González-Castro A, Rodiño-Janeiro BK, Salvo-Romero E, Fortea M, Pardo-Camacho C, Antolín M, Saperas E, Azpiroz F, Santos J, Alonso-Cotoner C. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Am J Gastroenterol 2020;115:2047-59. [PMID: 32740086 DOI: 10.14309/ajg.0000000000000789] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
652 Vergnolle N. Postinflammatory visceral sensitivity and pain mechanisms. Neurogastroenterol Motil. 2008;20 Suppl 1:73-80. [PMID: 18402644 DOI: 10.1111/j.1365-2982.2008.01110.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
653 Cibert-Goton V, Lam C, Lingaya M, Falcone Y, Wood JN, Bulmer DC, Spiller R. Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D. Clin Transl Gastroenterol 2021;12:e00313. [PMID: 33617189 DOI: 10.14309/ctg.0000000000000313] [Reference Citation Analysis]
654 Kirsch R, Riddell RH. Histopathological alterations in irritable bowel syndrome. Mod Pathol. 2006;19:1638-1645. [PMID: 17013373 DOI: 10.1038/modpathol.3800704] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
655 Santos J, Guilarte M, Alonso C, Malagelada JR. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol. 2005;40:129-140. [PMID: 15764142 DOI: 10.1080/00365520410009410] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
656 Yu Y, Ding X, Wang Q, Xie L, Hu W, Chen K. Alterations of Mast Cells in the Esophageal Mucosa of the Patients With Non-Erosive Reflux Disease. Gastroenterology Res 2011;4:70-5. [PMID: 27942317 DOI: 10.4021/gr284w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
657 Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011;23:754-e332. [PMID: 21615623 DOI: 10.1111/j.1365-2982.2011.01732.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
658 Drake MJ, Fowler CJ, Griffiths D, Mayer E, Paton JF, Birder L. Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms. Neurourol Urodyn. 2010;29:119-127. [PMID: 20025025 DOI: 10.1002/nau.20841] [Cited by in Crossref: 81] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
659 Soares RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol. 2014;20:12144-12160. [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 72] [Article Influence: 15.0] [Reference Citation Analysis]
660 Traini C, Evangelista S, Girod V, Faussone-Pellegrini MS, Vannucchi MG. Changes of excitatory and inhibitory neurotransmitters in the colon of rats underwent to the wrap partial restraint stress. Neurogastroenterol Motil 2016;28:1172-85. [PMID: 26972279 DOI: 10.1111/nmo.12816] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
661 Cremon C, Stanghellini V, Barbaro MR, Cogliandro RF, Bellacosa L, Santos J, Vicario M, Pigrau M, Alonso Cotoner C, Lobo B, Azpiroz F, Bruley des Varannes S, Neunlist M, DeFilippis D, Iuvone T, Petrosino S, Di Marzo V, Barbara G. Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. Aliment Pharmacol Ther. 2017;45:909-922. [PMID: 28164346 DOI: 10.1111/apt.13958] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
662 Aydinlar EI, Dikmen PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, Tozun N. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache. 2013;53:514-525. [PMID: 23216231 DOI: 10.1111/j.1526-4610.2012.02296.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
663 Moeser AJ, Pohl CS, Rajput M. Weaning stress and gastrointestinal barrier development: Implications for lifelong gut health in pigs. Anim Nutr 2017;3:313-21. [PMID: 29767141 DOI: 10.1016/j.aninu.2017.06.003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 63] [Article Influence: 22.5] [Reference Citation Analysis]
664 Martínez C, Vicario M, Ramos L, Lobo B, Mosquera JL, Alonso C, Sánchez A, Guilarte M, Antolín M, de Torres I. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations. Am J Gastroenterol. 2012;107:736-746. [PMID: 22415197 DOI: 10.1038/ajg.2011.472] [Cited by in Crossref: 124] [Cited by in F6Publishing: 118] [Article Influence: 13.8] [Reference Citation Analysis]
665 Yen EF, Pardi DS. Review article: Microscopic colitis--lymphocytic, collagenous and ‘mast cell’ colitis. Aliment Pharmacol Ther. 2011;34:21-32. [PMID: 21545473 DOI: 10.1111/j.1365-2036.2011.04686.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
666 Théodorou V. Susceptibility to stress-induced visceral sensitivity: a bad legacy for next generations. Neurogastroenterol Motil 2013;25:927-30. [DOI: 10.1111/nmo.12260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
667 Al-Khatib K, Lin HC. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver. 2009;3:14-19. [PMID: 20479895 DOI: 10.5009/gnl.2009.3.1.14] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
668 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017;23:6788-801. [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
669 Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology. 2007;132:615-627. [PMID: 17258716 DOI: 10.1053/j.gastro.2006.11.014] [Cited by in Crossref: 158] [Cited by in F6Publishing: 147] [Article Influence: 10.5] [Reference Citation Analysis]
670 Lied GA. Indication of Immune Activation in Patients with Perceived Food Hypersensitivity. Dig Dis Sci 2014;59:259-66. [DOI: 10.1007/s10620-013-2926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
671 Ibeakanma C, Ochoa-Cortes F, Miranda-Morales M, McDonald T, Spreadbury I, Cenac N, Cattaruzza F, Hurlbut D, Vanner S, Bunnett N, Vergnolle N. Brain-gut interactions increase peripheral nociceptive signaling in mice with postinfectious irritable bowel syndrome. Gastroenterology. 2011;141:2098-2108.e5. [PMID: 21856270 DOI: 10.1053/j.gastro.2011.08.006] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 5.8] [Reference Citation Analysis]
672 Zare-Mirzaie A, Lotfi M, Sadeghipour A, Haghi-Ashtiani MT. Analysis of colonic mucosa mast cell count in patients with chronic diarrhea. Saudi J Gastroenterol. 2012;18:322-326. [PMID: 23006460 DOI: 10.4103/1319-3767.101128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
673 Peeters M, Troost FJ, Mingels RH, Welsch T, van Grinsven B, Vranken T, Ingebrandt S, Thoelen R, Cleij TJ, Wagner P. Impedimetric Detection of Histamine in Bowel Fluids Using Synthetic Receptors with pH-Optimized Binding Characteristics. Anal Chem 2013;85:1475-83. [DOI: 10.1021/ac3026288] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
674 Canals M, Poole DP, Veldhuis NA, Schmidt BL, Bunnett NW. G-Protein-Coupled Receptors Are Dynamic Regulators of Digestion and Targets for Digestive Diseases. Gastroenterology 2019;156:1600-16. [PMID: 30771352 DOI: 10.1053/j.gastro.2019.01.266] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
675 Thijssen AY, Clemens CH, Vankerckhoven V, Goossens H, Jonkers DM, Masclee AA. Efficacy of Lactobacillus casei Shirota for patients with irritable bowel syndrome: . European Journal of Gastroenterology & Hepatology 2016;28:8-14. [DOI: 10.1097/meg.0000000000000484] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
676 Storr MA, Yüce B, Andrews CN, Sharkey KA. The role of the endocannabinoid sy